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ABSTRACT OF DISSERTATION 
 
 
 
 
AGE-RELATED ALTERATIONS IN THE DYNAMICS OF L-GLUTAMATE 
REGULATION IN THE STRIATUM OF THE FISCHER 344 RAT 
 
 
 L-glutamate is the predominant excitatory amino acid neurotransmitter in 
the mammalian central nervous system.  Prior aging studies have focused 
primarily on dopaminergic circuitry of the striatum, and data obtained studying 
glutamate regulation in the striatum have been largely equivocal.  These 
discrepancies are due in large part to the limitations of microdialysis; while it is 
extremely sensitive to minute concentrations of analyte, it is lacking in terms of 
the temporal resolution necessary to study a neurotransmitter with rapid release 
and clearance kinetics such as glutamate.  In order to address this matter, our 
laboratory has designed a ceramic-based multisite microelectrode with the 
capability to detect and analyze fluctuations in extracellular glutamate 
concentrations on a sub-second basis.  These microelectrodes were utilized to 
study the phasic release and uptake dynamics of potassium-evoked glutamate in 
the striatum of young (6 month), late-middle aged (18 month) and aged (24 
month) Fischer 344 rats.  Our results showed a reduced glutamate clearance 
rate and an attenuated response to potassium depolarization in the corticostriatal 
projections of aged animals in comparison to other age groups.  In addition, 
average maximal glutamate release amplitudes were decreased in the striatum 
of aged animals.  Pressure ejection of exogenous glutamate solution further 
confirmed the decreased glutamate clearance ability of the aged striatum.  These 
potassium and exogenous glutamate data also highlighted a marked 
dorsoventral gradient in the striatum in terms of glutamate release and clearance 
ability. We further explored this phenomenon of age-related decreased glutamate 
uptake by coupling our in vivo technology with classical immunoblotting and 
biotinylation techniques in order to investigate glutamate transporter regulation.  
Decreased glutamate clearance in the aged rats cannot be attributed to a 
reduction in steady-state total transporter protein levels.  Rather, our results 
indicate that reduced plasma membrane surface trafficking of GLAST in the aged 
striatum may be partially responsible for this effect.  Finally, we modified our 
microelectrodes to study basal glutamate levels in the striatum of the aging, 
freely moving rat.  This approach allowed us to study extracellular glutamate 
 regulation free from the potential confounding variable of anesthesia.  Our results 
demonstrate that there is no significant alteration in basal glutamate levels in 
aging in the brain regions investigated.  More importantly, this study validated the 
efficacy of the utilization of ceramic-based multisite microelectrodes for the study 
of alterations in glutamate neurotransmission in the aging, freely moving rat, and 
it lays the foundation for future work correlating such changes with age-
associated impairments in motor function.                      
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Chapter 1: Introduction 
 
 The term "aging" refers to a complex global series of events and 
processes that occur throughout the lifespan of an organism and ultimately result 
in a significant impairment in normal cellular functioning.  The cardinal physical 
manifestations of aging related to locomotion have been well established, those 
being, but not limited to, reduced motor movement velocity (bradykinesia), 
stooped posture and shuffling gait (Mortimer and Webster, 1982; Teravainen and 
Calne, 1983; Bennet et al., 1996).  Cognitive deficits have been observed as 
well, although the only consistent finding has been a marked decrease in the 
short-term memory of aged animals (Carey, 2002).  While these features of aging 
are of a very concrete nature, the molecular and cellular changes underlying 
these deteriorations are not quite as evident.  For instance, while the postural 
and motor impairments often observed with aging closely resemble those seen in 
individuals with Parkinson's disease, researchers have failed to implicate a 
substantial loss of dopaminergic neuron volume and transmitter content as being 
solely responsible for these deficits (for review, see Stanford et al., 2001b).  
Nonetheless, extensive aging research has been conducted in the basal ganglia, 
a neural network that operates in concert with the cerebellum and motor cortex 
for the initiation and progression of smooth, controlled locomotion. 
 
Anatomy and Physiology of the Basal Ganglia 
 
 The basal ganglia are an interconnected circuit of subcortical nuclei that 
collectively act to inhibit the initiation of undesired motor movements and 
maintain proper posture (Fig. 1.1).  An extensive review of the structures that 
comprise the basal ganglia is beyond the scope of this thesis, yet a fundamental 
understanding of the circuitry and its neurotransmitter components is crucial in 
the analysis and discussion of the alterations of glutamate neurotransmission in 
the aged striatum.   
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 The human striatum is located in the forebrain and is composed of two 
functionally distinct regions:  the caudate and putamen (dorsal striatum), which 
are delineated by the fibers of the internal capsule in primates and higher 
mammals, and the nucleus accumbens (ventral striatum), a pivotal structure in 
the reward/motivation pathway.  Being a rich, heterogeneous environment 
composed of cholinergic, dopaminergic, GABAergic, and glutamatergic axons 
and cell bodies, the dorsal striatum serves as the primary input to the basal 
ganglia for a wide variety of glutamatergic signals generated throughout the 
cerebral cortex.  These corticostriatal projections synapse on GABAergic medium 
spiny neurons in close proximity to cholinergic projections from large aspiny 
interneurons found in the area. 
 While the principle input to the striatum is glutamatergic in nature, another 
key component of the basal ganglia projects dopaminergic fibers to this region.  
The substantia nigra (SN) is located in the midbrain, and is also differentiated 
into two segments.  The substantia nigra pars reticulata (SNpr) receives 
inhibitory input from the striatum, as well as excitatory information from the 
subthalamic nucleus (STN), and plays a prominent role in eye movements.  The 
other subdivision of this region, the substantia nigra pars compacta (SNpc), is 
perhaps the most intensely researched component of the basal ganglia due to 
the finding that degeneration of this region is the prominent pathology in the 
brains of those afflicted with Parkinson's disease.  This densely cellular region 
provides the primary dopaminergic input to the striatum and forms synapses in 
close proximity to corticostriatal projections on the medium spiny neuron.  This 
juxtaposition of dopamine and glutamate allows for extensive interaction of these 
neurotransmitters and thus synaptic modulation at the level of the dendritic 
spines. 
 Signals processed in the striatum progress through the basal ganglia in 
one of two pathways depending on which variety of medium spiny neuron is 
stimulated.  These neurons, while morphologically homogenous, are 
heterogeneous in terms of peptide neurotransmitters and the other molecules 
they contain, and therefore may be characterized into two distinct populations.  
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Medium spiny neurons with dendritic spines that house D1 class receptors 
contain dynorphin and substance P, and stimulate adenylate cyclase upon 
binding of dopamine.  The peptide neurotransmitters found in the remaining 
neurons are enkephalin, and their D2 receptors serve an inhibitory role upon 
activation by dopamine.   
 Following stimulation of D1-containing neurons, GABAergic tone to the 
internal segment of the globus pallidus (GPi) and SNpr is increased, which leads 
to decreased GABAergic tone in the ventral lateral nucleus of the thalamus.  The 
thalamus then increases glutamatergic tone to the motor cortex, thus influencing 
motor movement.  Because of the non-circuitous nature of this route, it is termed 
the "direct", or striatonigral, pathway.  Signals processed via the striatopallidal, or 
"indirect", pathway follow a much more complex route.  Binding at D2 receptors 
inhibits GABA release in the external segment of the globus pallidus (GPe), 
which increases GABAergic tone at the subthalamic nucleus (STN).  This 
inhibitory action on the STN reduces glutamate neurotransmission at the 
GPi/SNpr, reducing GABAergic tone in the ventral lateral thalamus leading to an 
overall increased glutamatergic tone in the motor cortex.   
 
The Interaction of Glutamate and Dopamine in the Striatum 
 
 As previously mentioned, the dendrites of the medium spiny neuron are a 
juncture for the variety of neurotransmitters present in the striatum (Fig. 1.2).  
While the projections containing these transmitters may all synapse on a 
common dendrite, glutamate and dopamine projections often synapse in much 
closer proximity to one another; a large percentage of these projections have 
been discovered to share dendritic spines (Bouyer et al., 1984; Freund et al., 
1984).  As a result, glutamate/dopamine interplay is crucial in modulating 
information relayed from the cerebral cortex.  Researchers have postulated for 
well over a decade that pharmacological intervention at this juncture could act as 
a feasible means of treatment of the motor abnormalities and deficiencies 
observed in patients with motor-related disorders such as Parkinson's disease.  
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Therefore, it should come as no surprise that many groups have extensively 
investigated corticostriatal glutamatergic control over dopamine release. 
 In vitro experiments conducted in rat striatal brain slices have 
demonstrated a concentration-dependent increase in extracellular dopamine 
levels following the administration of glutamate (Giorguieff et al., 1977; Roberts 
and Sharif, 1978), a phenomenon that is blocked upon the application of the 
glutamate receptor antagonist glutamic acid diethlyester (Roberts and Anderson, 
1979).  In vivo push-pull methodology has been used as well to study this 
phenomenon.  Nieoullon et al. (1978) showed an increased concentration of 
dopamine in the striatum following electrical stimulation of the motor and visual 
areas of the feline cerebral cortex.          
 Following these discoveries, scientists strove to uncover the cellular 
mechanisms responsible for glutamate's facilitation of dopamine release in the 
striatum.  The actions of synaptic glutamate are mediated by a number of 
receptors located both pre- and post-synaptically.  Three classes of ionotropic 
glutamate receptors have been characterized based on their affinities for specific 
agonists: N-methyl-D-aspartate (NMDA), amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid (AMPA), and kainic acid.  Metabotropic glutamate receptors 
(mGluRs) are another family of receptors coupled to intracellular second 
messenger systems via G proteins, and consist of two classes.  mGluR1 
receptors (mGluR1, mGluR5) activate phospholipase C and adenylate cyclase, 
ultimately facilitating neurotransmitter release.  The remaining mGluRs inhibit 
neurotransmitter release by inhibiting cAMP production, thus making this 
subclass of receptor a key member of the presynaptic mechanism responsible for 
maintaining low levels of extracellular transmitter in instances of excessive 
glutamate overflow.   
 An overwhelming majority of prior studies have focused on the NMDA 
receptor's role in stimulating dopamine release.  Low concentration infusions of 
NMDA into the rat striatum strongly stimulate dopamine release, an effect that is 
tetrodotoxin (TTX)-dependent (Morari et al., 1993).  Likewise, this effect was also 
observed in the striatum of freely moving rats (Westerink et al., 1992), and 
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electrophysiological studies also support the notion that NMDA receptors play a 
key role in facilitating dopamine release (Overton and Clark, 1991).  Collectively, 
these data have led researchers to postulate that glutamate exerts its influence 
on dopamine release by binding to NMDA receptors present on the terminals of 
nigrostriatal afferents.  Similar results have been obtained following applications 
of AMPA (Desce et al., 1992; Wang, 1991) and kainate (Jin and Fredholm, 1994) 
receptor agonists and antagonists, and the behavioral effects of mGluR 
manipulation suggest glutamate receptor-mediated dopamine release (Sacaan et 
al., 1992), but the data available for these receptor classes is relatively scarce in 
comparison to those collected in studies of the NMDA receptor. 
 The effects of dopamine on glutamate release have been intensively 
researched as well.  While glutamate acts to stimulate the release of dopamine at 
the level of the medium spiny neuron dendrite, an elevation of extracellular 
dopamine corresponds with an inhibition of glutamate release.  This has been 
demonstrated in many in vivo studies, as stimulation of the ventral tegmental 
area of the midbrain, dopamine iontophoresis, and the administration of 
dopaminergic drugs all resulted in a reduction of stimulus-evoked excitatory 
responses from corticostriatal afferents (Pennartz et al., 1994; Floresco et al., 
2001; Yang and Mogenson, 1984).  In addition, the application of dopamine or D2 
receptor agonists to the bath medium of striatal brain slices resulted in a 
reduction of the amplitude of excitatory postsynaptic potentials (EPSPs) evoked 
by the electrical stimulation of corticostriatal pathways (O'Donnell and Grace, 
1994; Hsu et al., 1995; Levine et al., 1996).   
 Substantial evidence has accumulated to identify the D2 receptor as being 
primarily responsible for mediating these effects.  A neuroanatomical study 
localized these receptors to corticostriatal afferents originating in the prefrontal 
cortex (Wang and Pickel, 2002), and the medium spiny neurons of mice with a 
deficiency of these receptors exhibit larger amplitude depolarizations and an 
increased frequency of spontaneous activity in comparison to wild type mice 
(Cepada et al., 2001).  Collectively, these findings indicate that release of 
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dopamine from nigrostriatal afferents inhibits glutamate release in the striatum 
via a presynaptic D2-receptor mediated mechanism on corticostriatal projections.      
 
Previous Aging Research in the Striatum 
 
 A thorough understanding of the interaction between these 
neurotransmitters in the striatum is critical in researching alterations in glutamate 
neurotransmission for several reasons, the foremost being that a preponderance 
of prior aging studies in the basal ganglia have been conducted in dopamine 
circuitry, in particular the nigrostriatal pathway.  It has been widely known for 
nearly half of a century that the SNpc of those individuals afflicted with 
Parkinson's disease lacked dopamine (Ehringer and Hornykiewicz, 1960), and 
that the administration of the dopamine precursor L-dopa was effective at 
alleviating the motor abnormalities associated with this disease (Cotzias et al., 
1967, 1969).  Because many of the symptoms of Parkinson's disease 
(bradykinesia, shuffling gait) closely resemble the declines in motor function 
observed in aged individuals, the nigrostriatal circuitry became a popular target of 
research for those studying both Parkinson's disease and aging.   
 As a result, a literature search for alterations in dopamine transmission in 
aging yields a plethora of research relating to many aspects of cellular and 
molecular dopamine neuron functioning.  A previous widespread tenet of aging 
has been that age-related motoric abnormalities are due in large part to a 
reduction in the number of dopamine neurons.  While normal, non-pathological 
aging is accompanied with an approximate 50% reduction in tyrosine 
hydroxylase-immunoreactive neuron number, it has become apparent that cell 
loss alone cannot exclusively account for these deficiencies (West and 
Gundersen, 1990; West, 1993; West et al., 1994; Emborg et al., 1998).  Rather, 
these motoric declines are most likely due to a combination of a number of age-
related factors, including, but not limited to, reduced dopamine release and 
clearance, increased threshold for elicited electrophysiological responses, and 
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decreased dendritic branch volumes of medium spiny neurons (for review, see 
Stanford et al., 2001b). 
 
Glutamatergic Neurotransmission in the Young and Aged Striatum 
 
 Due to the extensive interaction between dopamine and glutamate and the 
well-documented alterations that occur in the dopamine circuitry in aging, it is 
only natural to assume that similar changes occur in the glutamatergic 
corticostriatal projections.  Unfortunately, minimal data are available pertaining to 
this subject.  The pathway of glutamate release, clearance, and metabolism in 
the young, healthy striatum, however, has been extensively studied (Fig. 1.3).  
Depolarization of corticostriatal projections results in the influx of calcium ions in 
the axon terminals, which in turn stimulate the binding of vesicular glutamate 
transporters (VGLUTs) to the presynaptic terminal membrane and the 
subsequent release of glutamate into the extracellular space.  Glutamate freely 
diffuses to the postsynaptic medium spiny neuron dendrite, at which point it binds 
to AMPA and NMDA receptors and induces the influx of sodium and calcium ions 
into the neuron.   
 The clearance of glutamate from the synapse is performed exclusively by 
a series of high-affinity, sodium-dependent excitatory amino acid transporters 
(EAATs).  This process is robust and rapid, as glutamate poses a severe 
excitotoxic threat to surrounding neurons if conditions arise that facilitate 
accumulation of the neurotransmitter in the extracellular space (Olney, 1969).  
The two transporters responsible for >90% of glutamate clearance, glutamate 
transporter (GLT-1) and glutamate-aspartate transporter (GLAST), are localized 
to neuroglia, while the remaining ~10% of glutamate is removed by the excitatory 
amino acid transporter (EAAC) located on the postsynaptic membrane of the 
medium spiny neuron.  The process of glutamate clearance takes advantage of 
the ion gradient established to drive neuron depolarization and so is extremely 
energetically favorable; co-transported with glutamate are three sodium ions and 
a proton, while a potassium ion is transported extracellularly (for review, see 
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Danbolt, 2001).  For a more thorough discussion of these transporters and their 
regulation, please see below and Chapter Four.  Once segregated in the glia, 
glutamate is metabolized to glutamine by the glial enzyme glutamine synthetase 
and returned to the corticostriatal neuron.  The mitochondrial enzyme 
glutaminase then converts glutamine to glutamate which is to be packaged inside 
VGLUTs.   
 The aspects of this pathway have been studied in the context of aging, 
yet, as already mentioned, the data are scarce.  Further complicating matters, 
the data that have been collected are equivocal to a large extent.  Total 
glutamate content is a parameter that has been studied in a number of brain 
regions.  Some researchers discovered a modest (10-20%) decrease in total 
glutamate levels (Price et al., 1981; Strolin-Benedetti et al., 1990, 1991), while 
others showed an apparent consistency of glutamate concentration in the 
striatum throughout aging (Saransaari and Oja, 1995; Wallace and Dawson, 
1990).  It must be noted that the striatum is a very heterogeneous structure (see 
Chapters Three and Four), suggesting that the obvious inconsistencies of these 
results may be due in large part to varying densities of corticostriatal projections 
in the different regions.  In order to address this issue, Donzanti and Ung (1990) 
conducted a series of experiments in which the goal was to differentiate eight 
regions of the striatum based upon their total glutamate content.  The results 
ranged from a significant increase in glutamate content of 40% in the aged 
anterior dorsolateral striatum to no alterations in regions such as the posterior 
dorsomedial striatum, yet in no regions was there a decrease in glutamate 
content as was indicated in studies by other groups.     
 The sensitivity of glutamate fibers is another area of interest for those 
studying aging in the striatum.  Glutamate release can be investigated both in 
vivo as well as in vitro through the usage of two different models; push-pull 
microdialysis allows for sampling of extracellular neurotransmitters following 
chemical stimulation, while brain slice and synaptosome preparations afford the 
investigator ease of use to analyze the content of glutamate in the superfusion 
medium.  Once again, the results are equivocal.  Two groups found a large 
 9 
decrease in the concentration of potassium-evoked glutamate in the aged 
striatum (Freeman and Gibson, 1987; Saransaari and Oja, 1995), while another 
found no change in the ability of the aged striatum to release glutamate despite 
the injection of a higher concentration of potassium (Corsi et al., 1997, 1999).  In 
terms of basal glutamate release in aging, some researchers showed an 
astounding 77-190% increase in non-stimulated extracellular glutamate 
(Freeman and Gibson, 1987; Massieu and Tapia, 1997), others indicated a 
decrease in glutamate levels (Corsi et al., 1997), and yet others found no change 
in basal levels (Saransaari and Oja, 1995; Porras and Mora, 1995; Corsi et al., 
1999).   
 The collective results that pertain to glutamate clearance in the aged 
striatum are inconclusive as well.  Price et al. (1981) and Najerahim et al. (1990) 
both discovered a curious decrease in uptake rate in middle-aged rats that was 
restored in the striatum of the aged animals.  A single investigator showed a 
significant increase in uptake rate in the aged rats, while others found no 
difference in glutamate clearance rates in aging (Palmer et al., 1994; Strong et 
al., 1984).  Taken together, these data make it difficult to definitively determine 
the nature of glutamate regulation in the aged rat striatum (refer to Chapter Three 
for discussion). 
 One finding that is without such contention concerns alterations in 
glutamate receptor density in aged animals.  NMDA receptor density in the 
striatum has been consistently reported to be moderately reduced (20-50%) in 
aged rats, regardless of the method used to assay for such a change (Cimino et 
al., 1993; Castorina et al., 1994; Wenk et al. 1991).  In addition, a concurrent 
marked decrease in NMDA receptor mediated response has been observed 
(Cepeda et al., 1996).  A single study found that no change in AMPA receptor 
density occurs in the aged rat striatum (Cimino et al., 1993), and no aging 
research has been conducted to determine if there are alterations of mGluR 
density in this region. 
 
 
 10 
Glutamate Transporters: A Brief Overview 
 
 The process of termination of glutamate neurotransmission is quite 
different from the clearance and metabolic mechanisms observed in other 
neurotransmitter systems.  There have been no synaptic enzymes identified to 
date that degrade extracellular glutamate to a significant degree, and while the 
presence of a presynaptic glutamate transporter remains plausible, all available 
evidence for such a transporter appear to have been collected using 
questionable experimental design (for review, see Danbolt, 2001).  This has led 
researchers to formulate and accept the general conclusion that glutamate is 
cleared from the synapse almost exclusively via an efficient system of 
transporters localized to the glia and postsynaptic neuron membrane surfaces.   
 The common molecular structure of these transporters has historically 
been a topic of debate.  The initial publications (Kanai and Hediger, 1992; Pines 
et al., 1992; Storck et al., 1992) describing the discovery of these transporters in 
the last decade postulated that their structures consist of either six, eight or ten 
putative transmembrane spanning domains (TM).  Hydropathy plots have 
confirmed that each transporter indeed possesses at least six TMs (Kanai et al., 
1993) with an extended extracellular sequence of amino acids between TM3 and 
TM4 (Slotboom et al., 1996; Grunewald et al., 1998; Seal and Amara, 1998) that 
is a site for transporter glycosylation (for review see Seal and Amara, 1999).  
Also without contention is the finding that both the carboxy and amino termini are 
intracellular (Lehre et al., 1995; Danbolt et al., 1998; Dehnes et al., 1998).  
Further work in this area has since shifted the consensus opinion to these 
transporters having eight TMs (for reviews see Danbolt, 2001; Slotboom et al., 
1999).  This understanding of the conserved nature of these transporters is 
necessary when interpreting data pertaining to the regulation of glutamate 
clearance in the aged striatum (Chapter Four).    
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Thesis Outline 
 
 As evidenced by this discussion of alterations of glutamatergic 
neurotransmission in the aged rat striatum, there is much remaining to be done.  
The work presented herein serves to expand upon the foundation of the 
regulation of glutamate release and clearance in aging.  In Chapter 3, we used a 
multisite ceramic-based microelectrode for rapid and low level measures of 
glutamate in vivo.  We measured the amplitude and clearance rate of phasic 
changes in glutamate release produced by local application of potassium by a 
micropipette placed adjacent to the recording sites in the striatum of anesthetized 
young (6 month), late-middle aged (18 month) and aged (24 month) Fischer 344 
(F344) rats.  Our results show that the amplitudes and clearance rates of 
potassium-evoked release of glutamate in the striatum are significantly 
decreased in aged rats as compared to the other age groups.  In addition, the 
sensitivity of glutamate fibers to depolarization with potassium was significantly 
decreased in the aged rats.  Taken together, these data are consistent with age-
related alterations in glutamate release dynamics, which may involve a 
compensatory mechanism for maintaining static glutamate concentrations within 
the striatum. 
 Chapter 4 further explores the potential molecular underpinnings of this 
reduced glutamate clearance ability.  Extracellular L-glutamate poses a severe 
excitotoxic threat to neurons and glia when unregulated, therefore low synaptic 
levels of this neurotransmitter must be maintained via a rapid and robust 
transport system.  The included study utilized in vivo electrochemical recordings, 
immunoblotting and biotinylation in young, late-middle aged and aged F344 rats 
to elucidate the potential role that glutamate transporters (GLT-1, GLAST, and 
EAAC1) may play in this mechanism.  We found that the decreased glutamate 
clearance efficiency is not due to a decrease in the production of total transporter 
protein among these three transporters.  Rather, a significant reduction in the 
amount of GLAST trafficked to the plasma membrane surface in the aged 
animals (~55% when compared to young rats) may be partially responsible for 
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this phenomenon.  These age-related alterations in extracellular L-glutamate 
regulation may be key contributors to the increased susceptibility of the aged 
brain to excitotoxic insults such as stroke and hypoxia, and may also play a role 
in age-associated motoric decline.    
 Chapter 5 chronicles the development of in vivo, freely moving 
voltammetric recordings as a tool in studying the aging of glutamatergic 
neurotransmission in the rat striatum.  This technology is a significant 
improvement over the anesthetized electrochemical recording preparations, as it 
affords us the opportunity to study glutamate release and uptake dynamics free 
from the influence of anesthetic, and also allows us to study the temporal 
dynamics of neurotransmitter regulation while an animal performs a behavioral 
task.  Data obtained from these experiments indicate moderate but insignificant 
changes in basal glutamate levels throughout aging.  This preliminary research 
will be pivotal in the design of future aging studies attempting to correlate age-
related motor dysfunction with altered glutamate neurotransmission in the 
striatum. 
 
Copyright © Justin Robert Nickell 2006 
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Figure 1.1 Circuitry of the Basal Ganglia 
Schematic illustrating the principle projections to the striatum and their various 
neurotransmitter components.  Checkerboard pattern represents dopamine 
projections, black arrows denote glutamate projections, and grey represents 
GABA projections; squares denote inhibition, while arrows represent neuron 
stimulation.  Please see text for an extensive discussion of these pathways.  
Adapted from Bar-Gad and Bergman (2001) 
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Figure 1.2 Diversity of Projections on the Medium Spiny Neuron 
Cholinergic projections from interneurons synapse on dendritic shafts, while 
GABAergic projections from neighboring medium spiny neurons synapse directly 
on the neuron cell body.  Corticostriatal glutamatergic and nigrostriatal 
dopaminergic afferents synapse on common dendritic spines.  The close 
proximity of these terminals allows for direct modulation of presynaptic 
neurotransmitter release, a phenomenon which may play a prominent role in 
age-related motor dysfunction. 
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Figure 1.3 Typical Striatal Glutamatergic Synapse 
Following its release, glutamate binds to AMPA, NMDA and mGluR receptors 
located postsynaptically to influence ion influx and subsequent EPSP generation.  
Glutamate neurotransmission is terminated exclusively via the high-affinity 
sodium dependent transporters (GLAST, GLT-1 and EAAC1) present primarily 
on the glial cell membrane and to a lesser extent on the postsynaptic membrane.  
Presynaptic mGluR's act as autoreceptors to diminish glutamate release in the 
event of excessive spillover.  At right is a magnified view of a standard 
transporter and the specific stoichiometry of the glutamate clearance process.       
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Chapter Two: Materials and Methods 
 
The F344 Rat as a Powerful Model of Aging 
 
 Aging is a multifaceted process that affects all aspects of the mammalian 
central nervous system at differing rates and to varying degrees.  Therefore, an 
appropriate animal model must be selected that demonstrates many of the 
physical and cellular manifestations observed in aged humans.  The rodent, 
specifically C57BL mice, Sprague-Dawley, Wistar, and the F344 rat, has 
traditionally been the model of choice for studying the aging of the nigrostriatal 
circuitry (Austad, 1997), as they exhibit marked age-related motor deficits.  The 
F344 strain of rat has an inherent advantage over other rodent strains in that it is 
inbred.  This high degree of genetic constraint limits the possibility that any of the 
alterations we observe in the aging of these animals are due to substantial 
genetic variation.  In other words, any increases in life longevity and quality 
amongst animals will be limited, as genetic "superiority" will not be a confounding 
factor in these experiments.  In addition, the body weight of these animals 
remains relatively consistent throughout their lifespan, limiting any maturation-
dependent alterations in brain volume (Masoro, 1990).  
 Researchers agree that there is slight variability in lifespan amongst the 
various rat strains utilized for studying aging (Masoro, 1990; Sprott and Austad, 
1996), yet a consensus has been reached as to when to classify a rat as "aged".  
All rat strains, including the F344 rat, are deemed aged upon reaching 22 months 
of age.  With this in mind, three age groups were selected for the study of age-
related alterations in glutamatergic transmission in the striatum: young (6 month), 
late-middle aged (18 months), and aged (24 months).  These age groups 
approximately simulate humans of the ages of 18, 54, and 72 years, respectively.  
The addition of the late-middle aged F344 rats circumvents the confounding 
variable of differential maturation processes, as studies concerning aging should 
always be conducted in more than two age groups (Coleman and Flood, 1987). 
 
 17 
Animals 
 
 Young adult (6 months, n = 31), late-middle aged (18 months, n = 28), and 
aged (24 months, n = 30) male F344 rats were obtained from the National 
Institute on Aging (Harlan Sprague Dawley, Inc., Indianapolis, IN) and used for all 
experiments.  Please refer to Table 2.1 for distribution of animals across 
experiments.  Protocols for animal use were approved by the Institutional Animal 
Care and Use Committee.  Animals were housed according to approved 
guidelines, with food and water available ad libitum. 
 
Anesthetized, In vivo Amperometric Studies 
 
 Microelectrode Fabrication 
 Ceramic-based multisite microelectrodes are mass produced in 
conjunction with Thin Films Technology, Inc. (Buellton, CA).  The fabrication 
process consists of a series of photolithographic techniques that have several 
distinct advantages over the various other methods used to fabricate 
microelectrodes.  Photolithography allows routine production of reproducible 
recording surfaces as small as 5-10 µm.  In addition, multiple microelectrodes are 
patterned onto a single fabrication substrate (2.5 cm x 2.5 cm), allowing for 
increased fabrication number at a decreased cost.  Finally, photolithographic 
methods are used to manufacture numerous microelectrode designs with 
multiple recording sites in well-defined, highly reproducible geometrical 
configurations (for review, see Hascup et al., 2006). 
 The particular recording site geometrical configuration selected for the 
anesthetized electrochemical recordings was the R1 configuration (Fig. 2.2).  
This configuration consists of an in-line alignment of four recording sites with 50 
µm spacing between sites.  Individual recording sites possess the dimensions of 
50 x 150 µm.  This configuration provides a larger recording distance that is 
useful in the study of larger brain regions or layered structures, such as the 
striatum.   
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 Microelectrode Preparation 
 The ceramic-based microelectrode arrays with platinum (Pt) recording 
surfaces were fabricated, assembled and selected for in vivo recordings using 
our previously published methods (Burmeister et al., 2000, 2002) (Fig. 2.5).  
Microarrays were first coated with Nafion (Sigma-Aldrich, St. Louis, MI) to 
enhance their selectivity in vivo for glutamate versus ascorbic acid or other 
anionic interferents (Gerhardt et al., 1984).  Fresh stock Nafion solution was 
placed in a 1.5 ml Eppendorf tube and allowed to thicken to room temperature for 
1 hour in a humidity-controlled dessicator.  The microelectrode tip was then 
lowered into the Nafion and rotated gently for approximately five seconds prior to 
being oven baked at 175°C for four minutes to remove any traces of humidity and 
to dry the Nafion film.  We have found that this procedure is optimal for attaining 
a desired selectivity of > 100:1 for ascorbate based on a calculated slope of at 
least 5 pA/micromolar glutamate.  Additional Nafion coatings resulted in a 
reduced glutamate sensitivity due to H2O2's inability to traverse a thicker layer of 
anion repellent, while the application of a thinner coat of Nafion led to a 
substantial increase in levels of background ascorbic acid in the striatum upon 
solution application (Burmeister et al., 2002). 
 Microelectrodes were then coated with L-glutamate oxidase to make them 
sensitive to glutamate in vivo.  A 10 µl solution consisting of 1% BSA, 0.125% 
glutaraldehyde, and 1% glutamate oxidase was prepared, and then applied to the 
Pt recording sites beneath a dissecting microscope.  A small drop of the enzyme 
solution (~0.10 µl) was suspended from a pipette tip and placed on the sensor 
site for 1-2 seconds.  If successfully applied, a thin, luminescent layer of protein 
was observed on the sensor sites when viewed under a dissecting microscope.  
To ensure that an adequate layer of enzyme was applied to the recording sites, 
and because we have observed that increasing layer thickness does not 
correspond to a decrease in glutamate sensitivity, two additional coats of enzyme 
were applied in the same manner.  Microelectrodes were then stored in a low-
humidity environment for at least two days to allow for optimal enzyme layer 
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curing time.  Please refer to Chapter Three for further discussion of the necessity 
of these layers. 
  
 Microelectrode Calibration 
 Constant voltage amperometry was performed using a FAST-16 high-
speed electrochemistry instrument (Quanteon, L.L.C.) using software (Fast 
Analytical Sensor Technology) designed for simultaneous four-channel 
recordings.  An Ag/AgCl reference electrode was placed in a continuously stirred 
solution of 0.05 M PBS (37°C, pH 7.4) in conjunction with the microelectrode 
operated at an applied potential of +0.7 V vs. Ag/AgCl reference electrode.  A 
recirculating water bath (Gaymar Co.) was utilized to maintain a constant buffer 
temperature of 37°C.  Amplifiers were adjusted to obtain a final gain of 200 pA/V 
for all recordings.  Calibrations were performed by achieving final buffer 
concentrations of 250 µM ascorbic acid and 10, 20, 30, and 40 µM L-glutamate 
through additions of aliquots of 20 mM ascorbic acid and 20 mM L-glutamate 
stock solutions.  Selectivity ratios for glutamate over ascorbic acid were 
calculated as well as the slope (sensitivity), limit of detection (LOD), and linearity 
(R2) for glutamate.   
 
 In Vivo Glutamate Measures in Anesthetized Rats 
 Electrode/micropipette assemblies used for the in vivo recordings 
consisted of a ceramic-based working electrode and a single-barrel (1 mm o.d., 
0.58 mm i.d. glass, A-M Systems, Inc., Everett, WA) micropipette.  The tips of the 
micropipettes had inner diameters of 10-15 µm, and were positioned 100 + µm 
between recording sites two and three of the microelectrode arrays.  They were 
attached to the printed circuit board holder of the ceramic-based multisite 
microelectrode using Sticky Wax (Kerr Brand). 
 Male F344 rats were anesthetized with urethane (1.25g/kg, i.p.) and 
placed within a stereotaxic frame for the performance of a craniotomy.  A three 
cm sagittal incision was made on the skin of the cranium, and underlying fascia 
was displaced with a cotton swab.  Bulldog clips were applied to limit the 
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movement of the skin while performing this procedure.  Using a common Dremel 
tool, a 2 mm x 2 mm square section of the skull cap was removed in the upper 
right quadrant relative to bregma and the sagittal suture.  Underlying dura was 
carefully excised with the aid of forceps.  A miniature (200 µm diameter) Ag/AgCl 
reference electrode was implanted into a site that was remote from the recording 
area to prevent drifting of the working electrode potential.  A KCl (70 mM KCl, 79 
mM NaCl, 2.5 mM CaCl2, pH 7.4; Chapter Three) or glutamate solution (5 mM L-
glutamate, pH 7.4; Chapter Four) was loaded into a single-barrel micropipette.  
The potassium solution was used to study phasic release of glutamate as 
described in Chapter 3, while the glutamate solution was used in Chapter 4 to 
determine the temporal dynamics of glutamate uptake.  The 
microelectrode/micropipette array was inserted into the striatum (AP +1.0 mm, 
ML -2.5 mm, DV -3.0 to -7.0 mm) of the rat brain; coordinates were calculated 
from bregma based on the rat brain atlas of Paxinos and Watson (1986).  
Volumes of KCl and glutamate solution were pressure-ejected from the 
micropipettes using a Picospritzer II (Parker Hannifin Corp., General valve 
operation) and monitored using a stereomicroscope fitted with a reticule 
(Friedemann and Gerhardt, 1992) (Fig. 2.3).  The FAST-16 recording system 
(Quanteon, L.L.C.) was used to record the resulting L-glutamate signals at the 
multisite microelectrodes.  Animals were euthanized at the conclusion of each 
recording session via an overdose of anesthetic. 
 
 Glutamate Release and Clearance Parameters    
 Chemical stimulation or the application of exogenous glutamate solution 
produces a glutamate signal with a very distinct graphical "fingerprint".  Figure 
2.4 illustrates the typical spike-shaped appearance of a glutamate signal that is 
representative of the fluctuation of extracellular glutamate concentration as a 
function of time.  Amplitude (µM) is simply a measure of the maximal extracellular 
L-glutamate concentration achieved following its evoked-release or application, 
while rise time (TR, sec) describes the time necessary to achieve this amplitude 
from onset of the origin of the signal.  TTotal indicates the time necessary for 
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glutamate levels to return to baseline and encompasses the entire duration of the 
signal. 
 Several other parameters exist that are useful in describing the clearance 
characteristics of the generated glutamate signals.  T50, T80, and T100 (sec) 
indicate the amount of time necessary to decay 50, 80, and 100 percent of the 
signal from onset of maximum amplitude.  K-1 (sec-1) is a decay rate constant 
(first exponential rate of fit) and is independent of signal amplitude.  This value is 
representative of the slope of the linear regression of the natural log 
transformation of these data over time.  Finally, uptake rate (µM/sec) is obtained 
by multiplying the K-1 rate constant by the maximum amplitude of the signal.         
 
 Potassium-Evoked L-Glutamate Release Data Analysis 
 Dose-response studies were conducted in each striatal recording site to 
determine the maximum potassium-evoked glutamate responses in the young, 
late-middle aged, and aged rats (young rats, n = 182; late-middle aged rats, n = 
304; old rats, n = 82).  Only signals ranging from 10-20 µM in amplitude were 
selected for analysis of the temporal properties of the release signals, as 
glutamate signals within this range were the highest that were consistently 
attainable in the aged animals.  Approximately 20 signals were obtained from 
each depth in the striatum (ventral positions -3.0 to -7.0 mm in 0.5 mm 
increments).  This resulted in a large total number of signals collected from the 
young (n = 401), late-middle aged (n = 318) and aged (n = 279) rats for the 
temporal analyses of the glutamate signals.  Data were analyzed using a one 
way analysis of variance followed by Tukey's post hoc comparisons.  Statistical 
significance was defined as p<0.05. 
 
 Exogenous L-Glutamate Clearance Data Analysis 
 Only signals ranging from 10-20 and 20-40 µM in amplitude were selected 
for analysis of the temporal properties of glutamate uptake, as uptake rate was 
discovered to increase as amplitude does the same (see Chapter Four for further 
discussion).  Approximately 20 signals were obtained from each depth in the 
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striatum (ventral positions -3.0 to -7.0 mm in 0.5 mm increments).  This resulted 
in a large total number of signals collected from the young (n = 1092), late-middle 
aged (n = 415) and aged (n = 838) rats for the temporal analyses of the L-
glutamate signals.  Because the number of data points obtained varies across 
animals, a nested between-groups analysis of variance (ANOVA), using 
SYSTAT's Multivariate General Linear Model (SYSTAT Software, Richmond, CA, 
USA), was used to separate potential variance resulting from individual 
differences in sample number from the main effects for experimental groups.  
Making an assumption that each data point represents an individual animal 
would be pseudoreplication, which artificially inflates degrees of freedom 
(Hurlbert, 1984).  The use of the nested between-groups ANOVA test does not 
assume that each data point was taken from an individual animal.  A categorical 
variable was included that labeled each data point according to the individual 
animal from which it was obtained.  By taking this approach, main effects for age 
groups were independent of variance due to differences in the numbers of 
samples per animal.  Analyses were followed by Tukey's post-hoc tests if 
statistical significance was evident from the omnibus F test.  Statistical 
significance was defined as p< 0.05. 
 
Total Transporter Protein and Biotinylation Assays 
 
 Tissue Dissection and Preparation for Immunoblotting 
 All animals were decapitated under urethane (1.25 g/kg, i.p.) anesthetic, 
and their brains rapidly removed and dissected in 1 mm coronal slices using a 
chilled rodent brain matrix.  The dorsal striatum was extracted from three or four 
slices using a 14-gauge needle, and the tissue was frozen at -70 ºC.  Frozen 
tissue samples were sonicated in 300 µl 1% sodium dodecyl sulfate solution (pH 
~8) using a Fisher 60 sonic Dismembrator.  Protein concentrations of the tissue 
samples were determined using the bichinchoninic acid method (BCA), and 
appropriate volumes of sample buffer were administered to achieve a final 
protein concentration of 2 µg/µl in each sample.  Following electrophoresis, 
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sample proteins were transferred overnight in Tris/glycine/methanol buffer onto 
nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA).  The blots were 
then placed in Ponceau stain to visualize and verify approximate protein loads, 
followed by a 1 hr. immersion in quenching buffer (a buffer that reduces non-
specific binding of the antibodies to protein) containing 1% polyvinylpyrrolidone 
and 0.05% Tween 20 for a minimum of 1 hr.  After a 1 hr. incubation in primary 
antibody, blots were incubated in appropriate secondary antibody (swine anti-
rabbit IgG (0.8 µg/ml) or rabbit anti-mouse IgG (1 µg/ml; Dako, Glostrup, 
Denmark) for 1 hr., followed by a 1 hr. incubation with [125I] protein A (specific 
activity 1.3 GBq/mg; Amersham, Piscataway, NJ).   
 
 Antibodies and Blot Immunolabeling 
 A guinea pig polyclonal antibody targeting the carboxy-terminus of GLT-1 
was purchased from Chemicon International (cat. # AB1783) and used at a 
dilution of 1 µg/ml.  A rabbit polyclonal antibody raised against the carboxy-
terminus of GLAST was purchased from Novus Biologicals (cat. # ab416) and 
used at a dilution of 1 µg/ml.  A monoclonal antibody targeting the carboxy-
terminus of EAAC1 was obtained from Chemicon International (cat. # MAB1587) 
and used at a dilution of 2 µg/ml.  These antibodies were used to assay both total 
transporter protein levels as well as plasma membrane-associated protein levels, 
and the amount of protein loaded to assay total levels of transporter (30 µg for 
GLT-1, 15 µg for GLAST, and 60 µg for EAAC1) was well within the linear 
working range of each particular antibody. 
 Quantification of total and plasma membrane-associated EAAT protein 
levels was carried out via autoradiography.  Immunoreactive portions 
corresponding to the protein of interest on the blots were detected, and these 
areas were excised and gamma radioactivity measured for each sample.  Please 
see Results in Chapter Four for an extensive discussion of biotinylation data and 
analysis.    
 In the EAAT plasma membrane expression study, plasma membrane-
associated EAAT was defined as EAAT-immunoreactivity (EAAT-IR) from Lamelli 
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Buffer eluant collected from avidin beads and normalized to EAAT-IR in the 
lysate (which represents total EAAT-IR present prior to avidin bead addition) in 
each sample. 
  
 Preparation of Crude Striatal Synapotosomes/Glial Plasmalemmal 
 Vesicles and Determination of Plasma Membrane-Associated EAAT 
 We assessed the plasma membrane content of EAAT in crude striatal 
synaptosomes/glial plasmalemmal vesicle preparations using the membrane 
impermeant biotinylating reagent, sulfosuccinimidobiotin (NHS-biotin).  This 
method has been previously established for studies of protein plasma membrane 
expression of DAT in these preparations (Salvatore et al., 2003; Zhu et al. 2005).  
Striatal tissue was homogenized in ice-cold 0.32 M sucrose and spun at 1000 x g 
for 10 min.  The resulting supernatant was spun at 12, 500 x g for 15 min. and 
the pellet containing the crude synaptosomes was suspended in Krebs 
bicarbonate buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 25 mM 
NaHCO3, Na2EDTA, 1.7 mM CaCl2, 10 mM glucose, 100 µM paraglyine, 100 µM 
ascorbic acid; bubbled with 95:5 O2:CO2).  500 µg total protein aliquoted from 
these preparations for each age group was incubated for 1 hr. at 4 ºC (a 
temperature that arrests endocytosis) in 500 µl of 1.5 mg/ml NHS-biotin in 
PBS/Ca/Mg buffer (138 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 9.6 mM 
Na2HPO4, 1 mM MgCl2, 0.1 mM CaCl2, pH 7.3).  Biotinylating agents were 
removed by twice rinsing the pellet formed, followed by a 30-min. incubation with 
ice-cold 100 mM glycine in PBS/Ca/Mg buffer.  Preparations were further washed 
three times with PBS/Ca/Mg buffer and then lysed in 300 µl Triton X-100 buffer 
(10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) containing 
protease inhibitors (1 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µM pepstatin, 250 µM 
PMSF).  Aliquots of these Triton-sonicated lysates were taken for subsequent 
normalization of total EAAT against the biotinylated fraction and the remaining 
lysate was centrifuged for 20 min. at 20,000 x g at 4 ºC to remove nuclear 
components.  The supernatants were then incubated with monomeric avidin 
beads (100 µl/tube) in the same buffer for 1 hr. at room temperature.  The beads 
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were then washed in Triton X-100 buffer and the adsorbed biotinylated proteins 
were eluted by incubating in Lamelli buffer (62.5 mM Tris, pH 6.8, 20% glycerol, 
2% SDS, 5% β-mercaptoethanol, and 5% bromophenol blue) for 20 min. at room 
temperature.  Two 20-min. elutions with Lamelli buffer were typically required for 
maximal elution of EAAT immunoreactivity.  The extracts were then processed 
for blot immunolabeling for EAAT as described above. 
 
 Total and Membrane-Associated Protein Data Analysis 
 All data were generated from individual rats.  Mean and SEM were 
determined from each result obtained from the total number of rats used for each 
study.  One-way analysis of variance (ANOVA) was used to determine any age-
related changes in EAAT total and membrane-associated protein levels.  We 
used Tukey's post hoc tests to determine significance among groups if the 
ANOVA results indicated a significant difference among the three age groups (p 
< 0.05). 
 
Drugs and Reagents 
 
 All chemicals were used as received unless otherwise stated.   
 
 Electrode Preparation and Calibration 
 Nafion (5% in a mixture of aliphatic alcohols and water), ascorbate, L-
glutamate monosodium salt, and glutaraldehyde were obtained from Sigma-
Aldrich.  L-glutamate oxidase was purchased from Seikagaku America, Inc.  0.05 
M phosphate buffered saline solution (PBS) was created using sodium chloride, 
sodium phosphate monobasic, and sodium phosphate dibasic obtained from 
Fisher Scientific (Fair Lawn, NJ).  Glutaraldehyde was stored at -20°C.  All 
solutions were prepared using distilled water, which was de-ionized using a 
Millipore water treatment system. 
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 Intracranial Pressure Ejection 
 All solutions administered intracranially were prepared in 0.09% saline 
solution, adjusted to pH 7.4, and filtered prior to use through a sterile syringe 
filter (0.22 µm pore size, Costar, Corning, NY).  All components of the 70 mM 
potassium (sodium chloride, potassium chloride, calcium chloride dihydrate) and 
5 mM glutamate were purchased from Fisher Scientific. 
  
 Immunoblotting and Biotinylation  
 NHS-biotin and monomeric avidin beads were purchased from Pierce 
Biotechnology (Rockford, IL).  Protease inhibitors were obtained from Sigma.  All 
other solutions pertaining to biotinylation were purchased from Fisher Scientific 
and Sigma unless otherwise stated. 
 
Copyright © Justin Robert Nickell 2006 
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Table 2.1 Distribution of Fischer 344 Rats Across Experimental Conditions  
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Figure 2.2 Ceramic-Based Pt Microelectrode (R1 Configuration) 
This geometrical configuration consists of four in-line recording sites, each 
measuring 50 x 150 µm with 50 µm spacing between sites. 
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Figure 2.3 Anesthetized In Vivo Glutamate Recording Apparatus 
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Figure 2.4 Extracellular L-Glutamate Signal Parameters 
Peak representative of a typical signal generated via application of 70 mM KCl 
and 5 mM L-Glutamate solution.  Please refer to text for detailed discussion of 
these parameters. 
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Figure 2.5 R1 Microelectrode Layer Schematic 
Extracellular L-glutamate diffuses to the microelectrode surface, at which point it 
contacts the glutamate oxidase layer.  Glutamate is metabolized to α-
ketoglutarate, a non-factor in the determination of synaptic glutamate, and H2O2, 
which traverses the Nafion layer and is oxidized at the Pt recording site surface 
at +0.7V vs. Ag/AgCl reference electrode.  This process generates two electrons 
per molecule of peroxide, thus the current produced is an indirect indication of 
extracellular glutamate concentration.  Note that the Nafion layer excludes 
potential negatively charged interferents via electrostatic repulsion. 
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Chapter Three: Age-Related Changes in the Dynamics of Potassium-
Evoked L-Glutamate Release in the Striatum of Fischer 344 Rats 
 
Introduction 
 
 L-Glutamate is the primary excitatory neurotransmitter in the central 
nervous system, and plays a primary role in a number of activities related to brain 
plasticity including motor behavior, cognition, and memory.  It is believed that 
alterations in glutamate release and uptake dynamics are partially responsible for 
the deficits in these functions that often occur with aging.  Prior studies of 
glutamate release, however, are equivocal (Segovia et al., 2001b).  Some 
studies have indicated that basal extracellular glutamate concentrations in the 
hippocampus of aged (24 months) rodents may rise to levels 94% greater than 
those found in young (6 months) animals (Freeman and Gibson, 1987).  By 
contrast, more recent studies have attempted to show that these levels in aged 
rodents may actually be 60% lower than in young animals (Saransaari and Oja, 
1995).  Similarly, researchers have observed increases, decreases, or no 
changes in basal extracellular glutamate levels in the aged striatum (Freeman 
and Gibson, 1987; Massieu and Tapia, 1997; Corsi et al., 1997).  Thus, it is 
unclear why there are major discrepancies in the literature regarding the 
regulation of glutamate release in aging. 
 Taken together, it may be that basal extracellular glutamate levels remain 
constant throughout aging in rodents.  However, these constant glutamate levels 
are not necessarily indicative of static glutamate release and uptake processes.  
Extracellular glutamate levels reflect a delicate balance between release and 
uptake, meaning that age-related decreases in release may be compensated by 
a regional decrease in uptake, and vice-versa (Segovia et al., 2001b).  It is 
difficult, therefore, to accurately postulate mechanisms for the possible 
alterations in glutamate dynamics as a result of aging, as prior studies using 
brain slice methods and microdialysis techniques provide only a "snapshot" of 
glutamate concentration at a particular time, and cannot differentiate between 
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neuronal and glial sources of glutamate (Timmerman and Westerink, 1997).  
Thus, they are limited in their capacity to provide us with the high temporal and 
spatial resolution necessary for studying release of fast neurotransmitters such 
as L-glutamate in the brain. 
 Contrasting data also exist for the phenomenon of glutamate clearance 
from the synapse in the cerebral cortex and striatum.  While most studies have 
demonstrated a reduction in clearance of glutamate by astrocytes in aged 
rodents (Wheeler and Ondo, 1986; Najerahim et al., 1990; Saransaari and Oja, 
1995; Vatassery et al., 1998), other have reported no change (Dawson et al., 
1989; Palmer et al., 1994) or an increase in astrocyte clearance ability (Strong et 
al., 1984).  Once again, despite the discrepancies in data, there is a general 
belief that aged rats have a lower uptake capacity for extracellular glutamate and 
a decreased number of high affinity glutamate transporters in the striatum and 
prefrontal cortex (Price et al., 1981; Wheeler and Ondo, 1986; Najerahim et al., 
1990; Vatassery et al., 1998; Saransaari and Oja, 1995).  However, it is difficult 
to interpret prior data, as researchers were limited in their ability to obtain a high 
degree of temporal and spatial resolution regarding glutamate uptake. 
 In order to more rapidly measure L-glutamate release dynamics in vivo, 
our laboratory has developed ceramic-based multisite microelectrodes for rapid 
measures in the intact brain (Chapter Two).  The enzyme-based microelectrode 
has been developed and characterized for second-by-second measures of L-
glutamate in the intact rat brain (Burmeister et al., 2000, 2002).  Phasic 
glutamate release is produced in vivo by pressure ejection of a potassium 
solution from a micropipette placed adjacent to the recording sites; the glutamate 
released from nearby presynaptic terminals forms hydrogen peroxide by its 
interaction with the glutamate oxidase coating on the microelectrode.  This 
hydrogen peroxide is directly proportional to the L-glutamate concentration and 
can be converted to extracellular L-glutamate levels by calibration.  This 
technology allows us to accurately measure phasic changes of glutamate 
concentrations within various brain regions on a second-by-second basis, while 
maintaining a high degree of spatial resolution (microns) (Burmeister et al., 
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2002).  The aim of this study was to utilize this technology to evaluate the 
amplitudes and temporal dynamics of potassium-evoked L-glutamate release 
and uptake in the young, late-middle aged, and aged F344 rat striatum.  In 
addition, the heterogeneity of this brain region was characterized according to 
the nature of its release and clearance properties throughout aging. 
 
Materials and Methods 
 
 Please refer to Chapter Two for an in-depth discussion of all matters 
pertaining to animal care, electrode preparation, generation of potassium-evoked 
glutamate signals, and data analysis. 
 
Results 
 
 Local applications of potassium for 1-2 seconds produced robust, 
transient, and reproducible changes in extracellular levels of L-glutamate in the 
striatum of the young, late-middle aged, and aged rats.  The average L-glutamate 
amplitudes were lower in both the late-middle aged (36.0 + 0.8 µM) and aged 
rats (18.9 + 0.8 µM) when compared to the young animals (41.7 + 1.2 µM; both 
p<0.001).  Thus, aging was seen to cause a robust decline in the maximal 
amplitude of L-glutamate signals recorded in the striatum of the aged rats as 
compared to young animals.  In addition, a small but significant decline in the 
release amplitudes was seen in the late-middle aged rats as compared to the 
young rats (Fig. 3.2).   
 Due to the age-related changes in potassium-evoked L-glutamate signal 
amplitudes, the L-glutamate release data were sub-divided into groups 
composed of 10-20 µM signals from all age groups to study the temporal 
dynamics of the signals in aging.  When examining glutamate release dynamics, 
the average volume of potassium necessary to evoke glutamate signals in the 
range of 10-20 µM was greater (*p<0.05) in the 24 month rats (204 + 12 nl) than 
in the young rats (169 + 8 nl).  Likewise, the average amplitude of extracellular 
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glutamate concentration achieved per nanoliter of potassium ejected was 
attenuated in the 24 month rats (0.09 + 0.006 µM/nl) as compared to young 
animals (0.15 + 0.007 µM/nl).  Interestingly, signals from the striatum of late-
middle aged rats showed an increased response to potassium (0.21 + 0.01 
µM/nl) in comparison to young rats (Figs. 3.1, 3.3). 
 Upon further examination of the data, L-glutamate uptake dynamics were 
also compromised in the aged rats.  When compared to young rats (3.9 + 0.08 
µM/sec), the L-glutamate uptake rate in 24 month rats (3.1 + 0.10 µM/sec) was 
significantly slower (***p<0.001) (Fig. 3.3).  Figure 3.2 illustrates this 
phenomenon in much greater detail, as it compares the time dynamics of 
individual signals representative of each of the three age groups.  While the 
release rate and total amplitude achieved were similar amongst the three age 
groups, the time necessary for complete removal of glutamate from the 
extracellular space in the 24 month rats was longer than in the 6 and 18 month 
old animals.  Thus, the time dynamics of potassium-evoked release of L-
glutamate were seen to be altered in the aged rat striatum as compared to the 
young and late-middle aged animals.   
 Depth-related alterations in potassium-evoked release and uptake in aging 
were examined as well.  The average uptake rate and amp/nl were calculated for 
each depth (DV -3.0 to -7.0 mm, 0.5 mm increments) and compared amongst 
age groups.  This analysis yielded an abundance of data and highlighted many 
age-related significant differences in glutamate release and clearance 
parameters.  In consideration of space and clarity, please refer to Figures 3.4 
and 3.5 for these results.  In terms of glutamate uptake rate, the significant 
reduction in global clearance rate in the aged animals mirrored in the dorsal 
regions of the striatum (DV -3.0 to -4.5 mm) was not present in the more ventral 
depths of this structure (DV -5.0 to -6.5 mm).  This disparity between age-related 
local and global alterations of glutamate regulation became more apparent upon 
analysis of corticostriatal projection excitability, as the global attenuation of 
apparent fiber excitability in the aged animals was only observed in the dorsal 
striatum (DV -3.0 to -4.5 mm), and the overall increase in excitability in the late-
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middle aged striatum was only found in the more ventral regions (DV -5.0 to -6.5 
mm).  Thus, global alterations in glutamate release and clearance in the striatum 
are a reflection of a compilation of these parameter averages at all depths of the 
structure.        
 
Discussion 
 
 L-glutamate is a neurotransmitter of extreme value to normal CNS 
functioning, and it possesses the capability to produce severe excitotoxic 
damage.  Therefore, it must be tightly regulated within the brain and in brain 
areas such as the striatum.  Our study indicates that while phasic release of L-
glutamate is detectable in the aged rat, significant decreases in release 
amplitudes and uptake rate occur in the aged rat brain.  In the young animals, 
potassium-evoked glutamate signals were robust and required smaller volumes 
of potassium to achieve glutamate concentrations equal to those recorded in 
aged rats.  Late-middle aged rats had L-glutamate signals with larger amplitude 
in response to the ejection of equivalent volumes of potassium when compared 
to young rats.  In addition, the potassium effects on glutamate fibers were 
diminished in aged rats, as there was a decrease in the apparent excitability in 
comparison to young rats.  Glutamate clearance was significantly compromised 
in the aged striatum as well.  This technology also permitted us to study depth-
related alterations in glutamate clearance and release in the layered striatum, 
which highlighted that the majority of changes found at individual depths were 
representative of the global alterations in these parameters.  Thus, the present 
studies employing the new ceramic-based microelectrodes for rapid measures of 
L-glutamate support that there are significant age-related changes in phasic 
glutamate release produced by local applications of potassium. 
 Previous studies of glutamate release and uptake in the aged rat striatum 
are inconclusive.  While there are reports of reduced potassium-evoked 
glutamate release that are in agreement with the results of our study (Freeman 
and Gibson, 1987; Saransaari and Oja, 1995), there is an overwhelming number 
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of studies supporting the idea that there is no net change in basal (Porras and 
Mora, 1995; Saransaari and Oja, 1995; Corsi et al., 1999; Segovia et al., 1999) 
or chemically induced (Donzanti et al., 1993; Sanchez-Prieto et al., 1994; Corsi 
et al, 1997) extracellular glutamate concentrations.  The data remain equivocal 
on the issue of increased clearance rate (Strong et al., 1984), decreased 
clearance rate (Wheeler and Ondo, 1986; Najerahim et al., 1990) or no change in 
clearance rate of glutamate uptake in aging (Dawson et al., 1989). 
 We believe that this discrepancy in prior studies is due in part to the 
limitations of the technique employed.  Microdialysis is lacking in terms of the 
high degree of temporal resolution necessary for studying neurotransmitters with 
rapid release and uptake dynamics such as L-glutamate.  In addition, this low 
degree of temporal resolution increases the likelihood of detecting non-neuronal 
glutamate; neuron-mediated glutamate release is rapid and is likely cleared from 
the extracellular space in a matter of seconds.  Over a time frame of several 
minutes, the glutamate obtained in microdialysis experiments reflects glutamate 
not only from neuronal stores, but from other sources as well.  In fact, much of 
this glutamate is not obtained via the fulfillment of classical release criteria, and 
many researchers prefer to explain this phenomenon as being a result of 
reversed-uptake by carrier-mediated processes.  This has been shown to occur, 
however, only in situations of excessive stimulation (Timmerman and Westerink, 
1997).  Our ceramic-based microelectrodes provide the sub-second temporal 
resolution necessary to give a more accurate representation of the dynamics of 
phasic changes in extracellular L-glutamate.  This allows us to better elucidate 
the possible compensatory mechanisms responsible for maintaining static 
extracellular glutamate concentrations in the rat striatum in young and aged rats. 
 Compensatory mechanisms are known to exist throughout the mammalian 
CNS, and these may very well explain the striatum's ability to maintain relatively 
stable basal glutamate concentrations during the aging process (Segovia et al., 
2001a).  As demonstrated by Cobo et al. (1993), neurons in the prefrontal cortex 
display a marked decrease in excitability in order to compensate for the loss of 
glutamatergic neurons in the frontal cortex.  In all, this results in no alteration in 
 38 
net basal glutamate levels.  Our studies are in accordance with this notion of 
decreased excitability, as corticostriatal glutamatergic nerve endings in aged rats 
require a greater amount of potassium stimulation in order to reach the threshold 
necessary for neurotransmitter release.  Further studies are needed to determine 
the mechanisms which may underlie this apparent change in excitability of L-
glutamate synapses in the aged rat brain. 
 This decrease in apparent excitability of glutamate fibers may be guarding 
striatal neurons from potential excitotoxic damage, as glutamate clearance rates 
are significantly attenuated during aging.  This carries with it several possible 
interpretations.  The first and most obvious hypothesis that could be drawn from 
these data would be that there is either a down regulation of EAAT's or a 
reduction in their efficiency.  Prior studies have confirmed that there is a 
decrease in the maximal velocity of glutamate uptake in synaptosomes from 
aged animals (Price et al., 1981; Wheeler and Ondo, 1986).  This would, 
however, only account for the neurons' contribution to glutamate clearance, 
which is relatively small in comparison to glial glutamate clearance (Danbolt, 
2001), and no data, to the best of our knowledge, currently exist on glial 
clearance rates in aged animals. 
 Regarding potential compensatory changes in aging, astrocytes have 
been shown to increase in number and activity in the aged brain (Brizzee et al., 
1983; David et al., 1997).  This could very well offset a loss of neuronal 
transporter efficiency.  An increase in the number of transporters, however, does 
not necessarily correlate with an increase in affinity (Segovia et al., 2001b), and 
there have been few studies conducted on the glutamate affinity of these 
transporters.  Recent studies in our laboratory indicate a reduction in glutamate 
clearance rates in aged animals (Chapter Four), which were associated with an 
indication of increased numbers of transporters in the plasma membrane of glia 
and/or neuronal synapses.  Clearly, additional studies are warranted to 
determine the effect of aging on the functional dynamics of glutamate release 
and uptake in the striatum and many other brain regions. 
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 The development of the microelectrode technology utilized in this study 
has allowed us to obtain new insights into the temporal dynamics of potassium-
evoked glutamate release and uptake in young and aged rat striatum.  A 
particular strength of this technology is its capability to investigate 
neurotransmitter temporal dynamics in several depths of a layered structure such 
as the striatum.  The performance of such an assay is especially critical when 
analyzing release and clearance in larger brain regions, as variance in the 
density and release characteristics of neuronal projections then becomes a 
potential confounding factor.  The heterogeneity of the striatum has been well 
characterized in a number of recent studies.  Segovia et al. (1999) showed that 
glutamate's facilitation of dopamine release was diminished in the ventral 
striatum of middle-aged and aged rats, yet there was no significant loss of this 
stimulatory effect during aging in the dorsal striatum.  Marked changes were also 
observed in neuronal activity in the ventral striatum in aged animals following the 
administration of amphetamine or a D2 receptor antagonist, an effect that was not 
present in the dorsal striatum (Crawford and Levine, 1997).  Moreover, 
Friedemann and Gerhardt (1992) highlighted a dorsoventral gradient with respect 
to the phenomenon of the amount of potassium stimulation necessary to evoke 
dopamine release in the striatum.  Collectively, these data suggest that 
dopaminergic and glutamatergic projections to the striatum are not uniform in 
terms of distribution and/or excitability.  In addition, our uptake assay indicates 
that the clearance properties of glial and postsynaptic glutamate transporters 
may change as a function of depth in aging animals as well.  Therefore, when 
attempting to investigate the temporal dynamics of transmitter release and 
uptake in the striatum, it is necessary to analyze these parameters at many 
depths of the structure and not simply infer that the data obtained from a single 
layer are representative of the structure as a whole.    
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Figure 3.1 Dose Dependency of Potassium-Evoked Glutamate Release 
Representative tracings depicting the volume of potassium solution necessary to 
elicit glutamate release of increasing amplitudes in both young (upper tracings) 
and aged (lower tracings) F344 rats.  Note the significant attenuation in response 
in the aged animals upon application of similar volumes of potassium solution.  
Potassium solution was applied at the time points indicated by arrows. 
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Figure 3.2 Potassium-Evoked Glutamate Uptake Rate: Representative 
Tracings 
Series of recordings showing differences in amplitude-matched, potassium-
evoked L-glutamate release dynamics in 6, 18 and 24 month old F344 rats.  Note 
the significantly slower uptake rate in the 24 month rats as compared to the 6 
and 18 month old animals.  Potassium solution was applied at the time points 
indicated by the arrows.  The figure inset shows the decrease in average 
maximum amplitude of potassium-evoked L-glutamate release that occurs in the 
rat striatum in aging. ***p<0.001 vs. young animal group based on one-way 
ANOVA followed by Tukey's post-hoc test.  
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Figure 3.3 Average Potassium-Evoked Glutamate Signal Parameters  
Average values in the different age groups were for 1) comparison of L-glutamate 
signal amplitudes, 2) volumes of potassium ejected, 3)L-Glutamate signal uptake 
rates, and 4) maximal glutamate signal amplitudes obtained per nanoliter of 
potassium ejected amongst the three age groups.  Each bar represents mean + 
SEM from seven animals in each age group. *p<0.05 and ***p<0.001 vs. young 
animal group based on one-way ANOVA followed by Tukey's post-hoc tests.  
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Figure 3.4 Depth-Related Alterations in Glutamate Uptake Rate in Aging 
Glutamate uptake rates were calculated at several depths within each animal 
(DV -3.0 to -7.0 mm) and compared amongst age groups.  Note the that while the 
dorsal striatum (DV -3.0 to -4.5 mm) exhibits a marked reduction in glutamate 
clearance ability in the aged animals in comparison to young rats, no such 
difference exists in the more ventral regions (DV -5.0 to -6.5 mm) of this 
structure.  Each bar represents mean + SEM from seven animals in each age 
group.  ***p<0.001 and **p<0.01 vs. young animal group based on one-way 
ANOVA followed by Tukey's post-hoc tests.  
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Figure 3.5 Depth-Related Alterations in Corticostriatal Excitability in Aging 
Excitability of corticostriatal projections (amp/nl) was calculated at several depths 
within each animal (DV -3.0 to -7.0 mm) and compared across age groups.  A 
reduction in the apparent excitability of corticostriatal fibers in aged animals was 
only observed in the more dorsal striatum (DV -3.0 to -4.5 mm), while an 
increase in excitability of these fibers in the late-middle aged rats was only found 
in the ventral striatum (DV -5.0 to -6.5 mm).  Above data are reported as mean + 
SEM from seven animals in each age group.  ***p<0.001, **p<0.01 and *p<0.05 
vs. young animal group based on one-way ANOVA followed by Tukey's post-hoc 
tests. 
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Chapter Four: Reduced Plasma Membrane Surface Trafficking of GLAST 
Mediates Decreased Glutamate Regulation in the Aged Striatum 
 
Introduction 
 
 L-glutamate is the predominant excitatory amino acid neurotransmitter in 
the mammalian CNS and plays a primary role in neural processes underlying 
cognition, behavior, and motor functioning (Collindridge and Bliss, 1987; Cotman 
et al., 1988; Mora and Cobo, 1990; Cobo and Mora, 1991; Schmidt et al., 1992).  
While important for normal CNS functioning, deficits in extracellular glutamate 
regulation pose a serious threat to the viability of surrounding neurons, as 
elevated synaptic glutamate concentrations greatly increase the risk of 
excitotoxic loss of neurons (Olney, 1969).  Glutamate dysregulation is also 
believed to be a major player in aging, as the aged CNS is very susceptible to 
excitotoxic insults from stroke or hypoxia (Liu et al., 1996; Brewer, 1998).  Thus, 
it is crucial that low extracellular glutamate levels be maintained via an efficient, 
rapid, and robust transport mechanism (Balcar and Johnston, 1972; Logan and 
Snyder, 1972; Johnston, 1981).  To date, five sodium-dependent EAAT subtypes 
have been cloned, and they act in concert as the exclusive means of terminating 
glutamate neurotransmission (Pines et al., 1992; Storck et al., 1992).  GLAST 
and GLT-1 are located primarily on astrocytes, and account for approximately 
ninety percent of all glutamate transport.  Postsynaptically, EAAC1 is responsible 
for removal of the remaining ten percent.  EAAT4 and EAAT5 have been 
characterized in humans and have very specific localizations, the cerebellum and 
retina, respectively, and so they are excluded from all discussions pertaining to 
the cerebral cortex and deep structures of the rat brain (for review, see Danbolt, 
2001). 
 Prior studies of aging in the striatum have not implicated these 
transporters as having a significant contribution to alterations in glutamate 
neurotransmission believed to play a role in age-related motor deficits and 
increased secondary damage susceptibility.  Further complicating matters, a 
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large portion of previous data pertaining to glutamate uptake are equivocal.  For 
example, Price et al. (1981) noted a decrease in glutamate uptake rate of 41%, 
with a concurrent 32% increase in transporter affinity in aged rat synaptosome 
preparations.  In contrast, Strong et al. (1984) reported attenuation in transporter 
affinity of 116%, with an accompanying increase in uptake rate of 84% in aged 
animals.  Furthermore, another study indicated no significant alteration in either 
glutamate uptake rate or affinity in the aged rat model (Palmer et al., 1994).     
 We believe that these inconsistencies are due in large part to limitations of 
the techniques employed; the analysis of glutamate release and clearance 
dynamics requires a technique that provides a high degree of temporal resolution 
(for review, see Segovia et al., 2001b; Timmerman and Westerink, 1997).  We 
recently used novel methodology to record glutamate release on a second-by-
second basis, which determined a reduction in glutamate uptake rate and a 
concurrent decrease in the apparent excitability of glutamate fibers (Nickell et al., 
2005).   However, our prior study did not address the potential mechanisms 
underlying the decrease in glutamate uptake rate.  The present study aimed to 
further explore this phenomenon by coupling in vivo electrochemical recordings 
of glutamate uptake with classical immunoblotting and biotinylation in order to 
determine the potential roles of total transporter protein levels and membrane 
surface trafficking of these transporters in this apparent age-related decrease in 
glutamate uptake rate. Collectively, the data support that changes in the surface 
expression of GLAST may contribute to decreased regulation of extracellular 
glutamate in the aged brain. 
 
Materials and Methods 
 
 Please refer to Chapter Two for an extensive discussion of all methods 
relating to the following research, including animal care, voltammetric recordings, 
immunoblotting, and biotinylation. 
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Results 
 
 A new recording approach was used to more directly investigate the 
regulation of extracellular L-glutamate in vivo. Local applications of exogenous L-
glutamate were used to directly investigate glutamate uptake and clearance time 
in the striatum of young, late-middle aged and aged F344 rats.  Rapid (1-2 sec.), 
local ejections of nanoliter volumes of  glutamate solution into regions of the 
striatum produced robust, transient, and well-defined elevations in extracellular 
glutamate concentrations, followed by a time period of rapid glutamate clearance 
(see Figs. 4.1, 4.2).  We investigated two ranges of signal amplitudes  for our 
temporal analyses of glutamate clearance, as our prior study (Nickell et al., 2005) 
showed that the average maximal potassium-evoked release of glutamate in 
young F344 animals was approximately 40 µM, while the average maximal 
amplitude of potassium-evoked L-glutamate release in the aged rat striatum was 
~20 µM.  Therefore, glutamate signal amplitude ranges of 10-20 and 20-40 µM 
were selected to simulate these two extracellular levels of L-glutamate clearance.  
It must be noted that it is impractical to compare glutamate signals with vastly 
differing amplitudes, as there is a direct correlation between synaptic glutamate 
concentrations and clearance rates.  Thus, the rate of glutamate uptake 
increases as extracellular levels of glutamate increase as seen in Figure 4.1.   
 The average extracellular glutamate concentration achieved with each 
application among the three age groups in the 20-40 µM range was similar, as 
there was no significant difference when comparing the young (30.10 + 0.17 µM), 
late-middle aged (30.07 + 0.23 µM), and aged (29.57 + 0.20 µM) signal 
amplitudes.  Likewise, no differences existed among the three age groups when 
comparing average signal amplitudes in the 10-20 µM range as well, as the 
signals obtained in the young (15.88 + 0.15 µM), late-middle aged (15.88 + 0.20 
µM) and aged (14.97 + 0.13 µM) rats did not vary much in amplitude (Fig. 4.3).    
 Our primary finding is that both the late-middle aged and the aged rat 
brain display a compromised ability to remove extracellular L-glutamate, as 
evidenced by clearance times using a parameter called T80. This measure is a 
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calculation of the time necessary to clear 80% of the maximum signal amplitude, 
and has proven to be an extremely reliable means to characterize clearance 
efficiency in prior studies of both the dopamine (David et al., 1998) and serotonin 
(Daws et al., 1998) systems of the brain.  Within the extracellular glutamate 
amplitude range of 10-20 µM, T80 values in both the 18 (7.41 + 0.15 sec.; p<0.01) 
and 24 month (8.85 + 0.29 sec.; p<0.001) rats were significantly prolonged in 
comparison to those in the 6 month (6.00 + 0.11 sec.) animals.  Likewise, T80 
values for 20-40 µM signals obtained in young rats (6.10 + 0.07 sec.) were 
significantly lower than those in the late-middle aged (7.80 + 0.10 sec.; p<0.001) 
and aged (8.70 + 0.18 sec.; p<0.001) animals (see Fig. 4.3).     
 Upon further examination of these signals, the data also showed a 
reduction in the rate at which the aged brain is capable of removing L-glutamate 
from the extracellular space when examining both signal amplitude ranges.  The 
glutamate transporters in the young animals were significantly (p < 0.001) more 
efficient (10.47 + 0.13 µM/sec.) in clearing glutamate in the 20-40 µM range than 
those in the aged animals (8.25 + 0.20 µM/sec.).  The clearance of glutamate 
signals in the 10-20 µM range was also significantly (p<0.001) more rapid in the 
young rats (4.62 + 0.10 µM/sec) than in the aged animals (2.70 + 0.10 µM/sec). 
Interestingly, while there was no significant difference in glutamate uptake in the 
late-middle aged striatum in comparison to the young animals in the 20-40 µM 
amplitude range, glutamate clearance in these animals (5.08 + 0.16 µM/sec) in 
the 10-20 µM range was significantly (p<0.01) faster than in the young or  aged 
groups. 
 Depth-related alterations in clearance time and uptake rate in aging were 
examined as well.  The average T80 and uptake rate were calculated at each 
depth (DV -3.0 to -7.0 mm; 0.5 mm increments) and compared amongst age 
groups.  This analysis yielded an abundance of data and highlighted many age-
related significant differences in glutamate clearance ability.  In consideration of 
space and clarity, please refer to Figure 4.4 and Table 4.5 for these results.  
Generally speaking, the relationship amongst age groups observed at dorsal 
depths (DV -3.0 to -4.5 mm) paralleled the above reported global effects in terms 
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of both uptake rate and clearance time.  However, when examining clearance 
times in more ventral regions of the striatum (DV -5.0 to -6.5 mm), the large 
discrepancy in T80 amongst the age groups is greatly diminished.  Thus, the aged 
rat striatum displays a marked dorsoventral gradient in its ability to clear 
glutamate from the extracellular space.   
 This age-related reduction in glutamate clearance time and uptake rate led 
us to investigate the possibility that perhaps this phenomenon is due, in part, to 
an attenuation in the production of total transporter protein.  When comparing the 
transporter responsible for the majority of glutamate clearance among the three 
age groups, GLT-1, no significant difference was found (Fig. 4.6A).  Likewise, 
there was no difference in either GLAST or postsynaptic EAAC1 total protein 
levels (Fig. 4.6B, C).  Thus, we can state with confidence that the decreased 
glutamate uptake rate we observe in aging is not due to reduced steady-state 
levels of transporter proteins.   
 We continued to explore the potential mechanism underlying this 
decreased clearance time and uptake rate by investigating relative plasma 
membrane surface expression of the glutamate transporters via a biotinylation 
technique.  In order to process striatal homogenates for the assessment of all 
three glutamate transporters from each animal, we determined expected signal 
(as cpm from using I125-protein A for detection) from each transporter based upon 
immunoreactivities given from each antibody and the aliquots used from each 
step of preparation: P2 fraction, lysate (representing all protein), supernatant 
from avidin bead spin (representing cytosolic protein), and two eluants from 
treatment of avidin beads with Lamelli buffer (representing plasma membrane 
protein).  The relative immunoreactivities of the three transporter antibodies were 
such that GLT-1 gave the strongest immunoreactivity per µg protein, followed by 
GLAST, and then EAAC1.  Aliquot volumes taken from each step were guided by 
these immunoreactivities and in accordance with general handling as described 
in previous studies (Salvatore et al., 2003; Gates et al., 2004; Zhu et al., 2005).  
Each assayed amount was calculated for total amount based upon aliquot 
volume, total volume of prepared sample, and total amount processed.  In Figure 
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5, the relative yields for each step in the processing of striatal tissue for 
assessment of GLT-1 is shown.  Briefly, a band of ~65-70 kDa was excised from 
the blot and counted for gamma radioactivity.  Total recovery of GLT-1 
immunoreactivities in the supernatant and eluant fractions was 73% of that 
obtained from the lysate.  Furthermore, assuming equal recovery of the GLT-1 
from both fractions, the percent of GLT-1 associated with the eluant fraction was 
~90% and that from the supernatant ~10%.  Therefore, it appears that the 
majority of this glutamate transporter is expressed at the plasma membrane (Fig. 
4.7). 
 No difference existed among the age groups when comparing GLT-1 and 
EAAC1 in terms of membrane surface-association (Fig. 4.8B).  However, when 
comparing the surface expression of GLAST among the three age groups, there 
was a significant reduction in surface expression in both the late-middle aged (42 
+ 11 %; p < 0.05) and aged (55 + 13 %; p < 0.01) striatum in comparison to the 
young animals (Fig. 4.8A).  Thus, a strong age-related decline in GLAST 
membrane surface-association was observed that is in accordance with our 
clearance time data. 
 
Discussion 
 
 Regulation of L-glutamate signaling presents the mammalian CNS with an 
interesting paradox.  While a great majority of all excitatory neurotransmission in 
the brain and spinal cord is mediated by glutamate (Fonnum, 1984; Orrego and 
Villanueva, 1993), slightly elevated extracellular concentrations of this 
neurotransmitter over a period of time establish a toxic environment for 
surrounding neurons (Olney, 1969).  As a result, maintenance of relatively low 
synaptic glutamate levels is critical for cell survival and proper neuron 
functioning.  The current study investigated glutamate clearance alterations in 
aging, as well as several potential mechanisms responsible for those changes.  
When examining the clearance times of amplitude-matched applications of 
exogenous glutamate, the data showed a significant decrease in clearance ability 
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in both the late-middle aged and aged rat striatum.  This age-related decrease in 
clearance ability was shown to demonstrate a marked dorsoventral gradient, as 
clearance times were prolonged in the dorsal striatum in comparison to the 
ventral striatum of the aged animals.  We also provided evidence to conclusively 
show that a potential alteration in total transporter protein levels in aging is not a 
feasible mechanism to explain this phenomenon.  Rather, it appears that an age-
related decrease in the membrane surface trafficking of GLAST is at least 
partially responsible for this slowing of glutamate clearance in the aged brain.  
 Interestingly, the late-middle aged rat striatum exhibits a slightly increased 
glutamate uptake rate in the 10-20 µM range despite a reduction in the glia 
membrane surface expression of GLAST in the animals of this age group.  A 
recent study conducted by Salvatore et al. (2003) discovered a more rapid 
dopamine clearance rate coupled with a reduction in the surface trafficking of the 
dopamine transporter of nigrostriatal projections in late-middle aged rats in 
comparison to young animals.  This finding validates the point that several 
factors are responsible for determining the net uptake rate of glutamate; while 
glutamate transporter steady-state protein levels and membrane expression are 
critical components of this process, affinity of these transporters must also be 
taken into consideration.  Therefore, the determination of the affinity of each 
EAAT in the striatum of all age groups is necessary in the future in order to more 
fully characterize the mechanism underlying impaired glutamate clearance, but 
the lack of selective transporter inhibitors makes this difficult at this time.  In 
addition, clearance curves of injected substances are comprised of both diffusion 
and transporter-mediated uptake processes (Cass et al., 1993), which further 
complicate the interpretation of the rate data.  We have previously determined 
that the 80% decline times, or T80's, of clearance signals are extremely reliable to 
characterize clearance of both the dopamine (David et al., 1998) and serotonin 
(Daws et al., 1998) systems of the brain.  In the present studies, the T80 values 
were found to be highly reproducible and correlated with changes in the surface 
expression of the glutamate transporters, analogous to the prior work of 
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Salvatore et al. (2003).  Therefore, we believe that T80 is a more reliable 
parameter for the study of the rapid temporal dynamics of glutamate clearance.  
 The marked dorsoventral gradient in clearance ability observed in the 
aged striatum holds important implications for investigations of the motor 
dysfunction that arises in senescence.  Several studies conducted by Hebert and 
Gerhardt (1998, 1999) discovered a compromised dopamine release capacity in 
aged animals that was met with a concurrent reduction in dopamine clearance in 
both the dorsal and ventral striatum.  This phenomenon is believed to be a 
crucial compensatory mechanism for maintaining the normal synaptic lifespan of 
dopamine in the aged brain.  While these alterations were observed throughout 
the striatum, our data indicate that glutamate uptake is compromised solely in the 
dorsal striatum.  Collectively, these data suggest that the primary motor circuitry 
of the striatum located in the dorsal depths of the region incur a reduction in 
glutamate clearance ability in order to sustain this transmitter's facilitation of 
dopamine release in the aged basal ganglia.  Additional studies are warranted to 
further characterize the chronology and molecular underpinnings of such age-
related changes.          
 Emerging data have identified a number of molecules as potential factors 
in the process of glutamate transporter regulation.   These glial and postsynaptic 
transporters share common putative protein phosphorylation sites in their primary 
amino acid sequences (Kanai et al., 1993), leading many researchers (Pisano et 
al., 1996; Casado et al., 1991; Sims and Robinson, 1999) to investigate the 
possibility that EAAT regulation is mediated by protein kinases, notably protein 
kinase C (PKC).  Data have shown that activation of PKC in C6 glioma cells 
rapidly increased cell surface expression of EAAC1 (Dowd and Robinson, 1996; 
Davis et al., 1998) and similar results have been obtained in primary cultures of 
neurons and astrocytes (Munir et al., 1997).  However, these data are in stark 
contrast with results obtained in alternate cell line models of other studies.  For 
example, EAAC1 activity and expression were decreased in Xenopus oocytes 
(Trotti et al., 1998, 2001) cell lines, while GLT-1 membrane expression was 
decreased in C6 glioma and primary cultures upon PKC activation (Kalandadze 
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et al., 2000; Robinson, 2002).  The equivocal nature of these studies continues 
when examining the influence of PKC activation on GLAST membrane trafficking, 
as researchers have noted increases, decreases, or no change in transporter 
surface association following an increase in activated intracellular PKC levels 
(Casado et al., 1991; Gonzalez and Ortega, 1997; Daniels and Vickroy, 1999; 
Gonzalez et al., 1999).  Taken together, these data show that glutamate 
transporter phosphorylation has differing effects that are dependent upon the 
particular cell line utilized for study.  Despite these inconsistencies, however, 
these studies clearly demonstrate that alterations in glutamate transporter 
membrane surface trafficking are a viable means whereby to regulate 
extracellular glutamate levels in vivo as well as in vitro. 
  While the focus on glutamate transporter regulation continues to intensify, 
scarce data, if any, are available on alterations of these transporters in aging.  In 
fact, a reduction in the density of NMDA receptors on the medium spiny neuron 
postsynaptic membrane (Petersen and Cotman, 1989; Mitchell and Anderson, 
1998) is the only finding that is without contention among researchers studying 
aging in the striatum.  Many prior studies have investigated the rate of glutamate 
clearance in the striatum, and the results have led to the general conclusion that 
glutamate uptake is compromised in the aged brain (for review, see Segovia et 
al., 2001).  However, one must use caution when interpreting these results, as 
the technique used in these studies (microdialysis) does not possess the 
necessary time resolution to completely study neurotransmitters with rapid 
release and uptake dynamics such as glutamate (Timmerman and Westerink, 
1997).  In addition, these data provide only indirect evidence of glutamate 
transporter regulation (Segovia et al., 2001).  To the best of our knowledge, our 
study is the first to demonstrate that the decrease in glutamate clearance 
efficiency observed in aging is due in part to a selective reduction in GLAST 
membrane surface trafficking and not a reduction in total EAAT protein levels. 
 The results obtained in this study hold promising implications for the field 
of aging research in the striatum.  It has been well established that the aged 
brain has an increased susceptibility to neurotoxic damage (Liu et al., 1996; 
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Brewer, 1998), yet a reduction in the concentration of antioxidants has been the 
only explanation offered for this phenomenon (Vatassery et al., 1998; Lynch, 
1998).  Our data provide further insight to this increase in susceptibility by 
examining the role of impaired glutamate transport and its potential contribution 
to the establishment of a neurotoxic environment in aging (see Fig. 4.9).  As we 
have shown, the glia in the aged striatum exhibit a 55% reduction in the 
trafficking of GLAST to the membrane surface, limiting its access to the 
extracellular environment and subsequently reducing the rate at which glutamate 
is cleared from the synapse.  Over time, this gradual elevation of tonic and 
phasic glutamate concentration may result in increased NMDA receptor 
stimulation, calcium and sodium influx, and reactive oxygen species (ROS) 
production (Bondy and Lee, 1993; Lafon-Cazal et al., 1993; Reynolds and 
Hastings, 1995; Savolainen et al., 1995).  These elevated ROS levels could lead 
to increased lipid peroxidation and glutamate transporter impairment via 
peroxidation byproducts such as 4-hydroxynonenal (HNE) (Springer et al., 1997; 
Pedersen et al., 1999; Keller et al., 1997; Blanc et al., 1998).  In addition, energy 
consumption of these medium spiny neurons may increase, as the ATP demand 
placed on the pumps responsible for restoring ionic gradients will be greater 
(Pellerin and Magistretti, 1994, 1997; Sibson et al., 1998; Novelli et al., 1988; 
Kohmura et al., 1990).  These are conditions that may be taxing to neurons over 
a prolonged period of time and may contribute to increased age-related damage 
of the CNS.  
 We conclude that the age-associated reduction in L-glutamate clearance 
efficiency in the striatum of the aged F344 rat is partially due to decreased 
membrane surface trafficking of GLAST.  Altered glutamate transport has long 
been implicated in the etiology of a number of neurodegenerative conditions in 
humans, including amyotrophic lateral sclerosis (Rothstein et al, 1992, 1995; Lin 
et al., 1998), episodic ataxia, seizures (Jen et al., 2005), and the age-related 
Alzheimer's disease (AD) (Cross et al., 1987; Cowburn et al., 1988).  
Researchers have more recently illustrated a strong relationship between AD and 
GLAST expression.  In transgenic mice with the London mutation (a mutation of 
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familial AD), a reduction in GLAST expression in the neocortex was observed 
(Masliah et al., 2000).  Likewise, biochemical studies have discovered reduced 
high-affinity L-glutamate uptake sites in cortex extracted from human brain tissue 
(Cowburn et al., 1988; Cross et al., 1987; Scott et al., 1995).  While a number of 
these studies attributed the link between disease and transporter to decreased 
GLAST production, more recent studies acknowledged that internal 
sequestration of transporters due to increased oxidative stress or amyloid beta-
peptide deposition could mask detection of a portion of the transporter pool from 
specific antibodies (Zoia et al., 2005; Butterfield and Lauderback, 2002).  Thus, 
there is a strong possibility that decreased GLAST membrane-association may 
play a role in AD etiology.  Another potential causative factor in AD pertains to 
the structure of the transporters themselves.  According to Scott et al. (1995), 
variant forms of GLAST are present in the cortex of Alzheimer's disease-afflicted 
brains.  Taken together, these alterations in GLAST may very well account for 
much of the neurotoxic pathology observed in this age-related disease, as well 
as the increased susceptibility to damage observed in ischemia and hypoxia.  
Even so, these data were collected in brain regions other than the striatum, and 
to the best of our knowledge no studies have been conducted in this region 
concerning GLAST expression and its correlation with neurotoxic damage.  
Clearly, additional studies are warranted to determine the role of GLAST in age-
related diseases and conditions in both animals and humans.        
  
Copyright © Justin Robert Nickell 2006 
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Figure 4.1 Glutamate Uptake Rate/Amplitude Correlation 
Glutamate clearance signals in the rat striatum. Shown are representative 
recordings illustrating the positive correlation between glutamate signal amplitude 
and uptake rate.  Tracings are comprised of signal amplitudes representative of 
potassium-evoked glutamate release in the old (Amplitude: 16 µM, Uptake Rate: 
4.38 µM/sec) and young (Amplitude: 35 µM, Uptake Rate: 13.5 µM/sec) F344 rat 
striatum, as well as a signal representing glutamate release dynamics well 
beyond the physiological range (Amplitude: 59 µM, Uptake Rate: 27.6 µM/sec).  
Indicated on the left and right tracings are the portions of the decay curve 
representing 80% glutamate clearance (T80), while the center tracing denotes the 
portions of the signal utilized for calculation of uptake rate (maximum amplitude x 
first order rate of the decay signal).  The figure inset shows glutamate signal 
amplitude versus uptake rate from signals recorded in a young animal (Pearson 
correlation coefficient = 0.7186, ***p<0.001).  
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Figure 4.2 Exogenous L-Glutamate Clearance: Representative Tracings 
Series of L-glutamate voltammetric recordings showing differences in amplitude 
matched L-glutamate clearance dynamics in 6, 18 and 24 month old F344 rats.  
Note the significantly prolonged glutamate clearance time in the late-middle aged 
and aged striatum in the left tracing, as well as the reduced glutamate uptake 
rate in the signal on the right tracing corresponding to an aged rat. L-glutamate 
solution was applied at the time points indicated by the arrows.   
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Figure 4.3 Average Exogenous Glutamate Clearance Parameters 
Average signal parameters from glutamate signals (10-20 and 20-40 µM) 
recorded in the striatum of 6, 18 and 24 month old F344 rats.  Average values in 
the different age groups were for 1) comparison of L-glutamate signal amplitudes 
and 2) the time necessary to clear 80% of exogenous glutamate in the striatum of 
young, late-middle aged and aged rats.  Each bar represents mean + SEM from 
six, four and seven animals in 6, 18 and 24 month old rats, respectively.  
***p<0.001 and **p<0.01 vs. young animal group based on nested between-
groups ANOVA followed by Tukey's post-hoc tests.   
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Figure 4.4 Depth-Related Alterations in Glutamate Clearance Time (T80) in 
the Striatum as a Function of Age  
The average T80 for each depth (DV -3.0 to -7.0 mm; 0.5 mm increments) was 
calculated and then compared amongst age groups.  Note that while the average 
T80 values of the young and late-middle aged animals display little variance 
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amongst depths, the prolonged clearance time found in the dorsal striatum of the 
aged rats is diminished as placement of the microelectrode proceeds in a ventral 
direction.  Each bar represents mean + SEM from six, four and seven animals in 
6, 18 and 24 month old rats, respectively.  ***p<0.001 and *p<0.05 vs. young 
animal group based on nested between-groups ANOVA followed by Tukey's 
post-hoc tests.   
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Table 4.5 Depth-Related Alterations in Uptake Rate as a Function of Aging 
The average uptake rates for each depth (DV -3.0 to -7.0 mm; 0.5 mm 
increments) were calculated and then compared amongst age groups.  
Glutamate uptake dynamics at most depths are representative of the structure as 
a whole, the notable exception for both amplitude ranges being the most dorsal 
depth studied (DV -6.0 to -6.5 mm).  Data represent mean + SEM from six, four 
and seven animals in 6, 18 and 24 month old rats, respectively.  ***p<0.001 and 
*p<0.05 vs. young animal group based on nested between-groups ANOVA 
followed by Tukey's post-hoc tests.   
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Figure 4.6 Striatal L-Glutamate Transporter Protein Levels as a Function of 
Age   
Western blots denoting striatal L-glutamate transporter total protein levels as a 
function of aging.  Numbers located below lanes for each transporter denote age 
of animals in months.  (A) Total GLT-1 levels per protein (cpm/µg; 30 µg per 
lane) in the striatum across the three age groups analyzed.  Data represent the 
mean + SEM of values (n = 6).  (B) Total GLAST levels per protein (cpm/µg; 15 
µg per lane) in the striatum across the three age groups analyzed.  Data 
represent the mean + SEM of values (n = 6).  (C) Total EAAC1 levels per protein 
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(cpm/µg; 60 µg per lane) in the striatum across the three age groups analyzed.  
Data represent the mean + SEM of values (n = 6).  
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Figure 4.7 Representative Biotinylation Assay 
Western blot representing the relative immunoreactivities obtained from each 
step of processing striatal homogenate for determining GLT-1 levels (~65-70 kDa 
band) in each cellular fraction.  For the P2 fraction, 15 µl of sample was loaded 
from 225 µl of sample volume; for lysate, 15 µl of 225 µl; for supernatant 
(representing cytosolic protein), 80 µl of 450 µl; for both eluants, 15 µl of 105 µl.  
During processing of striatal homogenates, 100 µl of 300 µl of sample 
(representing 500 µg of total protein) was set aside for lysate analysis.  Therefore 
the remaining 200 µl (representing ~330 µg protein) was processed for 
assessment of cytosolic and plasma membrane levels.  Sample volumes stated 
above represent volumes from sample handling steps plus the addition of sample 
buffer for electrophoresis.  The remaining volume of sample from each step was 
processed for analysis of GLAST and EAAC1.  Numbers above bands represent 
age group in months. 
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Figure 4.8 Striatal Synaptosome Protein Recoveries in Plasma Membrane 
(Bead Eluants) Fractions as a Function of Age   
(A) Western blot illustrating GLAST immunoreactivities in avidin bead eluant 
(representing plasma membrane fraction) from striatal synaptosomes from 6-, 
18- and 24-month-old rats.  Relative GLAST-IR in the eluted fractions was 
normalized to relative GLAST-IR for each age group in the lysates (representing 
total GLAST prior to the addition of the avidin beads).    For each experiment, the 
GLAST-IR in the 18- and 24-month-old fractions was compared against that in 
the operationally matched 6-month-old fraction (n = 5 animals per age group).  
Numbers located above lanes denote age group of animals in months.  Data 
presented in bar graphs represent mean + SEM from five animals in each age 
group.  Asterisks indicate a significant difference as compared to 6 month 
fractions (*p<0.05 and **p<0.01 vs. young animal group; Tukey's post-hoc test).  
(B) Relative GLT-1 and EAAC1 immunoreactivity in the avidin bead eluant.  The 
GLT-1 and EAAC1 immunoreactivity in the 18- and 24-month-old fractions was 
compared against that in the operationally matched 6-month-old fraction (n = 5 
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animals per age group).  Data represent mean + SEM for all age groups.
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Figure 4.9 The Role of GLAST in Glutamate Dysregulation  
Schematic of a young and aged striatal synapse illustrating the danger of a 
dysregulation of extracellular L-glutamate.  Note that an identical number of 
glutamate molecules are included in each diagram, and that an approximate 55% 
reduction in plasma membrane-associated GLAST has occurred in the aged 
schematic.  As this decrease in GLAST surface expression becomes prevalent in 
the aged striatum, extracellular L-glutamate concentrations become elevated, as 
is evidenced by the concurrent reduction in clearance efficiency.  This may lead 
to increased ionotropic NMDA receptor stimulation and elevated intracellular 
levels of Na+ and Ca2+ ions.  This is potentially detrimental to neuron viability, as 
this environment is conducive to the formation of increased levels of reactive 
oxygen species and ATP consumption (see Chapter Four Discussion).      
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Chapter Five: Investigations of Basal L-Glutamate Levels in the Aging 
Striatum: An In vivo, Freely Moving Amperometric Study 
 
Introduction 
 
 The strengths of the in vivo voltammetric technology employed in the 
studies of the previous chapters are great in number; it provides us with the high 
degree of spatial and temporal resolution necessary to study the rapid kinetics of 
glutamate, while also providing us a means to characterize temporal release and 
uptake dynamics as a function of regional depth.  It must be noted, however, that 
all previous applications of this technology were conducted in anesthetized 
preparations, and the potential effects of anesthesia on glutamatergic 
neurotransmission in the striatum have yet to be determined.  The anesthetic of 
choice for prior experiments, urethane, has been extensively studied in the 
dopamine circuitry of the brain.  The central nervous system depression imparted 
by urethane is mediated by the interaction of this drug with a wide variety of 
receptor classes, including glycine, GABA, NMDA, and AMPA receptors (Hara 
and Harris, 2002), and while urethane may depress neuronal activity in dopamine 
neuronal terminal fields, electrophysiological responsiveness to the indirect 
dopamine agonist amphetamine remains unaltered (Warenycia and McKenzie, 
1988).  This, along with the finding that dopamine uptake remains consistent 
following administration of urethane in the striatum of unrestrained rats (Sabeti et 
al., 2003), suggests that urethane is an optimal anesthetic for non-survival 
surgeries based on its minimal influence on dopaminergic motor circuitry.  No 
such studies, however, have been conducted to determine the potential effects of 
this drug's interaction with glutamate receptors and transporters.   
 The inability to study age-related deficits in motor functioning in 
anesthetized animals is another concern.  In vivo electrophysiological studies 
have provided great insight to dopaminergic motor neuron activity in aging.  
Stanford and Gerhardt (2001a) demonstrated an age-related decrease in 
amphetamine-induced firing rates of medium spiny neurons, as well as an 
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increased pre-drug intraburst firing rate in the amphetamine-excited neurons in 
the aged animals.  This increased basal firing rate of the medium spiny neurons 
has also been observed in other studies following the eradication of inhibitory 
dopaminergic afferents via 6-hydroxydopamine lesions, and is believed to be due 
in large part to the unchecked influence of glutamatergic corticostriatal 
projections (Centonze et al., 1999; Herrling and Hull, 1980).  While these 
experiments suggest that alterations in striatal glutamate dynamics may play a 
substantial role in the motor dysfunction of aged animals, there has yet to be any 
studies conducted to observe age-related differences in glutamate 
neurotransmission in awake young vs. aged rats.  More recently, the multisite 
microelectrodes utilized in the studies described in previous chapters have been 
configured for in vivo recordings of extracellular glutamate, and they have reliably 
detected alterations in glutamate concentrations upon repeated ejections of 
exogenous L-glutamate in the behaving animal.  Whisker stimulation-induced 
glutamate response in the striatum has been observed as well (Pomerleau et al., 
2003).  While the current state of the technology lacks the capability to accurately 
quantify the amount of drug ejected (< 1 µl) and characterize the heterogeneity of 
glutamatergic terminals within the striatum, it is important to consider the possible 
ramifications that anesthesia may have on glutamate signaling.  Therefore, this 
technology is extremely beneficial in examining the dynamics of corticostriatal 
glutamate in the awake, behaving animal.  This chapter chronicles the continual 
development of the chronic implantation of ceramic-based microelectrode arrays 
and their involvement in laying the foundation for future work correlating 
alterations in glutamate neurotransmission in aging with behavior. 
 
Materials and Methods 
 
 Microelectrode Design 
 The microelectrode recording site geometrical configuration selected for 
these studies was the S2 electrode (Fig. 5.1).  This configuration consists of four 
15 x 333 µm recording sites arranged in a rectangular formation, 30 µm spacing 
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between sites in an individual pair and a distance of 100 µm between pairs.  This 
particular recording site arrangement allows the investigator to employ a 
technique known as "self-referencing", a method valuable for further validating 
the purity and origin of all signals generated, that will now be discussed. 
 
 Microelectrode Selectivity 
   One issue that must be addressed in all experiments relying on the 
specific detection and analysis of a single neurotransmitter of interest is that of 
selectivity.  Currently, there are several techniques available to enhance the 
selectivity of the microelectrode arrays for L-glutamate.  The first method, as 
discussed in Chapter Two, is the application of a layer of Nafion film which 
serves to electrostatically repel negatively charged potential interferents such as 
ascorbic acid.  Varying the voltage applied to the Pt recording sites is another 
useful tool in eliminating signal components which may be attributed to 
interferents.  By reducing the applied voltage from +0.7V to +0.2V, most peroxide 
may no longer be oxidized at the surface of the electrode recording site.  
Dopamine and other molecules, however, may still be detected at this voltage.  
The discrepancy in signal between the two voltages can then be interpreted as 
glutamate's contribution to the signal generated at +0.7V vs. Ag/AgCl reference 
electrode.   
 A third method that was utilized for this study is self-referencing 
(Burmeister and Gerhardt, 2001; Day et al., 2006).  Figure 5.3 illustrates the 
concept of this technique.  Briefly, the microelectrode recording site pair in 
closest proximity to the ceramic tip was rendered sensitive to glutamate via the 
normal addition of the glutamate oxidase/glutaraldehyde/BSA matrix as 
described in Chapter Two.  The remaining recording site pair was coated with an 
inactive matrix of simply glutaraldehyde and BSA, resulting in sites nearly 
identical to the other pair with the exception that these lack the capability to 
detect glutamate.  Following the conclusion of each recording session, basal 
glutamate levels were calculated as described below. 
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 Microelectrode Preparation 
 Microelectrodes utilized in freely moving recordings must undergo 
extensive modification prior to implantation and the determination of basal 
glutamate levels (Fig. 5.2).  The initial step in converting the electrode to a stable 
device for implantation is the addition of four 30 AWG varnished copper wires, 
each corresponding to a single Pt recording site.  Approximately 0.5 mm sections 
of both ends of each wire were stripped prior to one end being soldered to a pin-
hole on the row nearest the microelectrode tip as depicted in Figure 5.2B.  The 
other end was soldered to a gold-plated socket amphenol (Ginder Scientific Part 
#220-S02).  The microelectrode was then coated with five minute epoxy to 
protect the connections from moisture damage for the remainder of the 
procedure.  All microelectrodes were then coated with Nafion and the glutamate 
oxidase/BSA/glutaraldehyde matrix as previously described. 
 The final steps of the conversion process were conducted one day prior to 
implantation.  All amphenols were firmly inserted into a miniature connector 
(Ginder Scientific, 9-pin ABS Plug, Part #GS09PLG-220) with the aid of pliers so 
that all amphenols were completely encased.  A miniature Ag/AgCl reference 
electrode was prepared and inserted in a similar fashion (Fig. 5.2C).  All copper 
wires were wrapped around the connector and the microelectrode positioned 
parallel to the longitudinal axis of the connector.  Five minute epoxy was 
administered to the microelectrode/connector apparatus to insulate all 
connections from moisture damage and to secure the microelectrode in position. 
 
 Microelectrode Calibration/Recording Apparatus 
 The recording of glutamate signaling in the awake, freely moving rat 
dictates that the equipment utilized for anesthetized in vivo recordings be 
modified in such a way as to allow for greater stability in the mobile animal.  
Therefore, the recording setup for these experiments varies greatly from that 
used to record in anesthetized rats.  The headstage attaches directly to the rat 
microelectrode assembly, connecting the chronically implanted microelectrode to 
the FAST-16 recording system.  This headstage is comprised of a miniature 
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connector with five connector pins designated for each of the four recording sites 
and the Ag/AgCl reference electrode.  The connector pins lead to a four channel 
mini-amplifier positioned in close proximity to the animal in order to minimize 
noise artifacts.  Shielded connecting wire leads to an electrical swivel 
(commutator) at the ceiling of the recording chamber that contains twelve 
electrical contacts.  This configuration is optimal for allowing free rotation of the 
headstage as the animal navigates the recording chamber. 
 In vitro calibrations were conducted as per the methods outlined in 
Chapter Two (Fig. 5.4). 
  
 Microelectrode Implantation 
 Surgical implantation was conducted in its entirety in a Vertical Laminar 
Flow Workstation (Microzone Corp., VLF-2-4).  Animals were anesthetized with 
sodium pentobarbital solution (50 mg/ml) administered in a single injection prior 
to being placed in a stereotaxic frame.  All hair immediately surrounding the 
surgical area was shaved, and an iodine solution was applied to the shaven area 
in order to prevent potential infection.  A 2 mm midline sagittal incision was made 
and the skin reflected with bulldog clamps.  All underlying fascia was gently 
displaced with a cotton swab, and the skull thoroughly cleaned with saline 
solution to enhance the viewing of the skull sutures.  A craniotomy was 
performed as described in Chapter Two.  Four additional holes (< 0.5 mm 
diameter) were created for placement of the Ag/AgCl reference electrode and 
three stainless steel skull screws (Small Parts Inc., Part #MPX-080-02-M).  The 
microelectrode/connector apparatus was implanted into the dorsal striatum (AP 
+1.0mm, ML -2.5 mm, DV -5.0 mm; vs. bregma) based on coordinates provided 
by the rat brain atlas of Paxinos and Watson (1986).  The assembly was secured 
with the addition of approximately four layers of Hygenic cold cure dental resin 
(Island Dental Co., Inc., Catalog #844-0794) mixed with Jet Acrylic Liquid (Lang 
Dental Manufacturing Co., Inc., Reference #1406) which adhered tightly to the 
skull screws.  This dental resin mixture covered the microelectrode/connector 
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and all exposed wires, with great care taken to prevent resin from adhering to the 
threads of the microelectrode connector. 
 Rats were permitted to recover on a heating pad (37ºC) to maintain body 
temperature as the animals awakened from the anesthetic.  Three subcutaneous 
injections of 1 ml Ringer's Solution (Fisher Scientific, Catalog #S77939) were 
administered subcutaneously to enhance recovery.  All animals were allowed 
three days to recover prior to the initial recording session.   
  
 Basal Glutamate Recording Sessions 
 Recording sessions were conducted on days four, five and six following 
microelectrode implantation.  All animals were allowed 20 minutes to acclimate to 
the recording chamber prior to connecting them to the FAST-16 system.  
Following the initiation of the recording software, approximately one hour was 
necessary for all channels to attain a stable baseline reading, at which time data 
relating to basal glutamate concentration were collected.  At the conclusion of 
each recording session (~2 hours), stress-evoked glutamate levels were 
measured as well.  A clothespin was placed at the base of the tail for a five 
minute period, followed by a thirty minute stress-free time period in order to allow 
glutamate concentrations to return to basal levels.   
 
 Data Analysis 
 Basal and stress-evoked glutamate levels were obtained and analyzed 
from young (n = 7), late-middle aged (n = 6) and aged (n = 5) F344 rats.  Basal 
glutamate concentrations were obtained by averaging glutamate levels over a ten 
second time period following the attainment of a stable baseline on channels 
rendered sensitive to glutamate, and then subtracting concentrations obtained on 
the accompanying self-referencing channel from this value.  Due to the inherent 
redundancy of each microelectrode, each self-referenced recording pair yielded 
two striatal basal glutamate levels per day, per animal, resulting in a moderate 
number of values for each age group.  Data were analyzed via a one-way 
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analysis of variance (ANOVA) followed by a Tukey's post-hoc test.  Statistical 
significance was defined as p<0.05.   
 
Results 
 
 The primary aim of these experiments was to validate the efficacy of the 
ceramic-based microelectrode array as a useful tool to study aging in the 
striatum of the freely moving F344 rat.  As illustrated in Figure 5.5, self-
referenced recording of basal glutamate in the striatum resulted in the production 
of dual representative tracings at each electrode recording site pair.  A simple 
process of subtraction of these two values yielded average basal glutamate 
concentration (see Materials and Methods).  While the average basal glutamate 
concentration of the late-middle aged striatum (6.27 + 2.15 µM) was reduced in 
comparison to the young (7.20 + 1.19 µM) and aged (7.09 + 1.58 µM) animals, 
no significant difference existed amongst the rats of all three age groups (Fig. 
5.5). 
 An inherent advantage that this technology affords us is the capability to 
further resolve these data to study alterations of basal glutamate levels within 
age groups on several days.  While no significant difference existed amongst 
basal glutamate concentrations within age groups on the days selected for 
recording sessions, this data analysis highlighted an interesting age-related 
phenomenon.  Basal levels of the young animals decreased slightly on day five 
(4.74 + 1.51 µM) in comparison to the initial day of recording (5.30 + 1.54 µM), 
yet basal glutamate concentration approximately doubled in magnitude on day 
six post-implantation (9.58 + 2.38 µM).  This phenomenon is also present in the 
striatum of the aged animals, as basal glutamate levels on day four (6.50 + 0.82 
µM) and five (6.15 + 1.31 µM) were similar, while concentration on day six (10.00 
+ 3.48 µM) was much greater in magnitude.  In addition to highlighting a potential 
biological effect of a lack of acclimation to the recording process, this effect 
confirms that the microelectrodes did not exhibit a reduction in sensitivity 
throughout the three days selected for the recording sessions.  This 
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phenomenon, however, is reversed in the late-middle aged rats.  Basal glutamate 
levels were elevated on the initial day of recording (9.19 + 3.86 µM) in relation to 
both day five (2.75 + 2.12 µM) and six (3.94 + 0.26 µM) (Fig. 5.6).     
 Our data also demonstrate that the administration of a tail pinch stressor 
to the animals results in a strong response in the glutamate circuitry of the 
striatum.  A typical bi-modal tail pinch stress response is depicted in Figure 5.7.  
Upon the application of the stress, extracellular glutamate levels increased 
rapidly to maximum amplitude (1-2 sec.) followed by a time of clearance and 
sharp fluctuations in baseline that customarily spanned the duration of the tail 
pinch stressor (Fig. 5.7).   
 
Discussion 
 
 The utilization of ceramic-based microelectrode arrays for the study of 
glutamate dynamics in anesthetized animals has proven to be a powerful tool in 
prior aging research conducted in our laboratory.  Several key issues regarding 
the current state of the technique, however, must be addressed in order to 
continue the evolution of this technology.  For instance, while the urethane 
anesthetic selected for use in the non-survival surgeries described in Chapters 
Three and Four has been demonstrated to exert minimal influence over certain 
aspects of dopaminergic neurotransmission, emerging data within our laboratory 
have shown that the administration of urethane to awake, freely moving F344 
rats reduces basal glutamate levels in the striatum upwards of 40% (unpublished 
observations).  In addition, previous electrophysiological data suggest that 
alterations in the release and/or uptake properties of glutamatergic corticostriatal 
projections may play a prominent role in the motor dysfunction observed in 
normal aging (Stanford et al., 2001b), and the anesthetized animal preparation is 
limited in terms of its capability to properly study this hypothesis.   
 The current study validates that the modification of our ceramic 
microelectrodes for chronic implantation in the F344 rat is a feasible method 
whereby to research alterations in glutamate neurotransmission in the aging 
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striatum.  Here we have demonstrated that, with the aid of self-referencing to 
enhance the selectivity of the microelectrode, basal glutamate levels are not 
significantly altered in either the late-middle aged or aged animals in comparison 
to young rats.  Also, while not significant, basal levels tend to rise as a function of 
time in the young and aged animals, an effect that is reversed in the late-middle 
aged rats.  Finally, our data prove that the effects of a manual stressor may be 
observed in the glutamatergic motor circuitry of striatum. 
 As mentioned previously, data obtained following the administration of 
urethane to the freely moving F344 rat suggest that glutamate release and/or 
uptake processes may indeed be impaired by this anesthetic.  A recent 
investigation conducted by Day et al. (2006) that utilized the ceramic-based 
multisite microelectrode array technology documented throughout this 
dissertation validated this finding.  Briefly, a basal glutamate level of ~2 µM in the 
striatum of the young, anesthetized F344 rat was determined via a variety of 
approaches, including the application of the universal glutamate transporter D,L-
threo-β-benzyloxyaspartate (TBOA) and implementation of the self-referencing 
technique outlined within this chapter.  In addition, local application of 
tetrodotoxin resulted in no significant alteration in basal glutamate levels, 
indicating that the basal extracellular glutamate concentrations obtained in this 
study were derived almost exclusively from neuronal origin.  These basal 
glutamate levels are approximately one-third of the magnitude of those 
calculated in the young, freely moving animal, thus further highlighting the 
importance of eliminating the confounding variable of anesthetic when studying 
basal glutamate release and clearance properties.                      
 Many groups have recently attempted to investigate changes in glutamate 
regulation in the freely moving rat via microdialysis.  Once again, however, it is 
crucial to consider the significant limitations imparted by this technique when 
interpreting these data.  Microdialysis provides the user with a high degree of 
sensitivity (picomolar) and the ability to identify a number of analytes of interest, 
yet it is particularly lacking in terms of temporal resolution.  The typical sample 
obtained by the performance of microdialysis is representative of analyte 
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concentration over a period of several minutes, yet there have been significant 
strides in recent studies to overcome this limitation; Kennedy et al. (2002) 
coupled microdialysis on-line with capillary electrophoresis to attain a temporal 
resolution of six seconds.  Nonetheless, this study still lacks the subsecond time 
resolution necessary to study the rapid dynamics of glutamate and has yet to be 
conducted in an awake, freely moving animal. 
 Another important consideration when employing a technique that involves 
chronic implantation and neurotransmitter sampling in the brain of an awake 
animal is that of mechanical disruption and damage of surrounding neurons and 
glia.  An intricate study conducted by Clapp-Lilly et al. (1999) investigated this 
phenomenon in the striatum of freely moving rats following microdialysis probe 
placement.  Briefly, light and electron microscopy were utilized to examine the 
morphological and subcellular characteristics of neurons immediately 
surrounding the area of implantation.  Evidence of non-excitotoxic damage to 
axons was found at the maximum distance observed from probe placement (1.4 
mm), and an estimate of neuronal density revealed a significant loss in volume 
up to a distance of 400 µm.  Cellular organelles such as mitochondria and 
endoplasmic reticula also displayed swelling and bloating, characteristics of 
necrosis-induced damage.  These processes may be significant confounding 
factors in studies using microdialysis to study neurotransmitter release in freely 
moving animals.   
 In comparison, chronically-implanted ceramic-based microelectrodes 
induce minimal tissue damage in the striatum.  Density of astrocytes surrounding 
the microelectrode tract remains unaltered over a period of eight weeks, and the 
number of activated microglia in the area are not significantly elevated 
(unpublished observations).  Taken together, these observations indicate that 
data collected using these microelectrode arrays may be more indicative of 
normal physiological neurotransmitter release and clearance than those obtained 
using more traditional methods of analysis such as microdialysis.   
 Nonetheless, a preponderance of all previous freely moving aging studies 
have been conducted using microdialysis.  Thus, we must interpret our results in 
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light of these studies while keeping these technical limitations in mind.  Our 
primary finding of no alteration in striatal basal glutamate levels in aging is in 
accordance with the data obtained from a number of prior studies (Segovia et al., 
1999, 2001a; Del Arco et al., 2001).  As discussed previously, glutamate release 
in the striatum is not an isolated function, as corticostriatal projections receive a 
high degree of modulation from adjacent dopaminergic projections.  A recent 
study by Segovia et al. (1999) examined this neurotransmitter interaction in the 
context of aging in awake rats.  Briefly, a universal glutamate uptake inhibitor, L-
trans-pyrrolidine-3,4-dicarboxylic acid (PDC), was perfused throughout the rat 
striatum in varying concentrations to increase extracellular glutamate levels, and 
the effects of these increased glutamate concentrations on dopamine release 
were observed.  It was discovered that while glutamate has a slightly elevated 
ability to facilitate dopamine release in the middle-aged animals, there were no 
significant alterations in glutamate-dependent dopamine release characteristics 
in all age groups in comparison to young rats.  This finding, coupled with data 
that demonstrate no changes in basal dopamine levels in the aging striatum 
(Segovia et al., 1999; Santiago et al., 1993; Kametani et al., 1995), suggests that 
if dopamine's inhibitory influence on glutamate release remains unaltered in late-
middle aged and aged rats it is not beyond the realm of possibility that basal 
glutamate levels remain consistent as well. 
 It is important to note that while both microdialysis and current 
voltammetric freely moving studies remove the confounding factor of anesthetic, 
they lack the capability to study basal glutamate concentration as a function of 
depth.  Due to the heterogeneous nature of the striatum as described in Chapters 
Three and Four, it may be incorrect at this point in time to deem the basal 
glutamate levels obtained in our study as representative of the entire striatum.  
Rather, they are indicative of basal levels at a depth of five millimeters in the 
dorsal striatum.  There also remains the possibility that regional compensatory 
mechanisms could temporarily mask reduced glutamate clearance or release at 
this depth, resulting in no net alteration in basal glutamate levels (please refer to 
Chapter Three for compensation discussion).  Thus, it will be necessary to 
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investigate phasic glutamate release and clearance in the freely moving rat in 
future studies. 
 Several key additions to the freely moving recording apparatus will make 
such studies a possibility in the near future.  To address the issue of the current 
apparatus' inability to accurately eject minute volumes of solution (i.e. < 1 µl 
potassium and glutamate) into the vicinity of the microelectrode, a fluid 
commutator will be implemented.  The stationary nature of the current 
microelectrode must also be remedied in order to better study the regional 
aspects of glutamate regulation in the layered striatum.  This will be 
accomplished following completion of the development of a microdrive that will 
be compatible with the microelectrode/connector assembly and allow for 
dorsal/ventral movement of the microelectrode within an animal. 
 These preliminary results have reliably shown that the modification and 
implementation of ceramic-based microelectrodes for the study of basal 
glutamate levels in the awake, freely moving animal is both practical and 
necessary.  The ultimate goal for this technology is to study glutamate temporal 
release and uptake dynamics during the performance of a behavioral task 
designed to examine motor efficiency.  There is strong electrophysiological 
evidence implicating dysfunctional glutamate neurotransmission in age-related 
motor deficiencies.  Nonlocomotor-related striatal neurons were found to exhibit 
increased firing rates and bursting activity during both bouts of locomotion and 
periods of non-movement, suggesting that tonic hyperactivation of the 
striatopallidal pathway of the basal ganglia may play a prominent role in the 
bradykinesia observed in aged animals (Stanford and Gerhardt, 2004).  This 
increased activity is believed to be due in large part to the unchecked release of 
glutamate at the level of the medium spiny neuron, as both dopamine release 
(Friedemann and Gerhardt, 1992; Kametani et al., 1995; Rose et al., 1986) and 
the D2 receptors responsible for mediating their inhibitory action on glutamate 
release are diminished in aging (Crawford and Levine, 1997; Han et al., 1989; 
Hyttel, 1987).  Clearly, additional studies are warranted to determine glutamate 
release and uptake dynamics in the striatum of the freely moving, aged F344 rat. 
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Figure 5.1 Ceramic-Based Pt Microelectrode (S2 Configuration) 
This arrangement consists of four paired microelectrode recording sites in a 
rectangular formation.  Each recording site has dimensions of 15 x 333 µm, with 
30 µm spacing between sites in a pair and a distance of 100 µm between pairs. 
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Figure 5.2 Freely Moving Microelectrode Array Preparation 
Series of photographs illustrating the various alterations necessary to convert an 
S2 microelectrode to the lighter model utilized for freely moving recordings.  A) 
The printed circuit board and attached ceramic microelectrode tip.  Numbers 
denote individual electrode recording site channels. B) Scored and cut circuit 
board holder with galvanized copper wire soldered into each channel.  C) 
Amphenols containing wires corresponding to each channel positioned in 
connector.  D) Fully assembled connector/microelectrode array and freely 
moving rat connector (top).  The headstage circuit board is illustrated at center.     
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Figure 5.3 Self-Referencing S2 Microelectrode Layer Schematic 
Photomicrograph (center) of S2 microelectrode array and schematics (left, right) 
describing preparation of electrode for self-referencing recordings.  Recording 
site pair depicted by (A.) are prepared as described in Figure 2.5, while the 
remaining recording site pair (B.) is prepared in a similar fashion, the notable 
exception being the lack of glutamate oxidase.  This technique provides the 
investigator with another means to validate the purity of all signals obtained via a 
method of subtraction.  Please refer to Materials and Methods for further 
discussion.   
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Figure 5.4 Sample Self-Referencing Microelectrode Calibration 
Representative tracings illustrating the enhanced selectivity of self-referencing 
microelectrodes.  The black tracing represents a channel coated with Nafion and 
the glutamate oxidase/glutaraldehyde/BSA mixture, while the blue tracing is 
representative of a channel coated with simply the exclusion layer beneath the 
glutaraldehyde/BSA mixture (sentinel channel).  Note that while both channels 
lack a response to the ascorbic acid interferent, only the channel rendered 
sensitive to L-glutamate via the application of the enzyme layer responds to 
subsequent additions of glutamate.  The application of peroxide confirms that the 
sentinel site's lack of response to glutamate is due to the absence of the enzyme 
layer and not simply a malfunction of the microelectrode recording site. 
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Figure 5.5 Basal Glutamate Recordings in the F344 Striatum in Aging 
Sample striatal basal glutamate concentration recording from a young F344 rat 
as a function of time.  As described in the text, basal glutamate levels were 
calculated by subtracting the average concentrations recorded on the sentinel 
sites from those recorded on the glutamate oxidase-coated sites over a period of 
ten seconds upon the attainment of a stable baseline.  As a result, the disparity 
between these values (as shown above) is a visual representation of the basal 
glutamate concentration.  The inset displays the average striatal basal glutamate 
concentrations amongst the three age groups.  All data represent mean (µM) + 
SEM from seven young, six late-middle aged and five aged F344 rats. 
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Figure 5.6 Time-Dependent Alterations in Basal Glutamate in Aging 
Data representative of basal glutamate alterations over the course of the three 
day recording sessions.  Note the sharp increase in basal glutamate 
concentration on the final day of recording in both the young and aged animals, 
while basal levels in the late-middle aged rats are reduced over time.  All data 
represent mean (µM) + SEM from seven young, six late-middle aged and five 
aged F344 rats.     
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Figure 5.7 Stress-Evoked L-Glutamate Release 
Sample representative tracing of stress-evoked glutamate release upon the 
application of a manual stressor.  A clothespin was placed at the base of the tail 
following the attainment of a stable baseline, resulting in a rapid and robust 
increase (~80 µM) in extracellular glutamate concentration, followed by a period 
of clearance from the synapse.  Sharp fluctuations in basal glutamate are present 
throughout the duration of the tail pinch stressor following the initial rise in 
glutamate levels.   
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